Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
45000,,,19366390,[],CHEMBL4423978,Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis isolate 7 after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4422644,Eur J Med Chem,2019.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3241322,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,8.0
45001,,,19366395,[],CHEMBL4423979,Antitubercular activity against multidrug-resistant Mycobacterium tuberculosis isolate 8 after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4422644,Eur J Med Chem,2019.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3241322,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,16.0
45002,,,19409570,[],CHEMBL4427291,Antibacterial activity against Acinetobacter baumannii ATCC BAA-1710D assessed as bacterial growth inhibition after 8 hrs by turbidimetric plate reader method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4425161,Bioorg Med Chem Lett,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3244206,=,1,0,=,,MBC,umol/L,,1.6,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MBC,umol/L,,,1.6
45003,,,19431892,[],CHEMBL4429190,Antimicrobial activity against aminoglycoside-resistant Klebsiella pneumoniae ATCC BAA-2470 measured after 24 hrs by double-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4428061,J Med Chem,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245818,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
45004,,,19431893,[],CHEMBL4429189,Antimicrobial activity against aminoglycoside-resistant Escherichia coli ATCC BAA-2452 measured after 24 hrs by double-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4428061,J Med Chem,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245818,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
45005,,,19431894,[],CHEMBL4429188,Antimicrobial activity against aminoglycoside-resistant Burkholderia cepacia ATCC 25416 measured after 24 hrs by double-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4428061,J Med Chem,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245818,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC,ug ml-1,UO_0000274,,32.0
45006,,,19431895,[],CHEMBL4429187,Antimicrobial activity against Acinetobacter baumannii ATCC 19606 measured after 24 hrs by double-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4428061,J Med Chem,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245818,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
45007,,,19431896,[],CHEMBL4429186,Antimicrobial activity against Escherichia coli ATCC 25922 measured after 24 hrs by double-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4428061,J Med Chem,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245818,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
45008,,,19431897,[],CHEMBL4429185,Antimicrobial activity against Klebsiella pneumoniae ATCC 10031 measured after 24 hrs by double-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4428061,J Med Chem,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245818,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
45009,,,19431898,[],CHEMBL4429184,Antimicrobial activity against Klebsiella pneumoniae ATCC 13883 measured after 24 hrs by double-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4428061,J Med Chem,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245818,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
45010,,,19431899,[],CHEMBL4429183,Antimicrobial activity against Haemophilus influenzae ATCC 10211 measured after 24 hrs by double-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4428061,J Med Chem,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245818,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,8.0
45011,,,19431900,[],CHEMBL4429182,Antimicrobial activity against Haemophilus influenzae ATCC 49247 measured after 24 hrs by double-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4428061,J Med Chem,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245818,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,8.0
45012,,,19431901,[],CHEMBL4429181,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 measured after 24 hrs by double-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4428061,J Med Chem,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245818,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
45013,,,19431902,[],CHEMBL4429180,Antimicrobial activity against Pseudomonas aeruginosa ATCC 47085 measured after 24 hrs by double-dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4428061,J Med Chem,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245818,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
45014,,,19432009,[],CHEMBL4429191,Binding affinity to 16S rRNA A-site in Escherichia coli S30 extract assessed as inhibition of translation measured after 30 mins by coupled transcription/translation-based luciferase reporter gene assay,B,,,BAO_0000190,BAO_0000225,nucleic acid format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4428061,J Med Chem,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,7.0,0,http://www.openphacts.org/units/Nanomolar,3245818,=,1,1,=,,IC50,nM,,100.0,CHEMBL614640,,Ribosomal RNA A-site,,,,IC50,uM,UO_0000065,,0.1
45015,,,19432021,[],CHEMBL4429192,Inhibition of cytosolic eukaryotic translation in rabbit reticulocyte S30 extract measured after 60 mins by coupled transcription/translation-based luciferase reporter gene assay,A,,,BAO_0000190,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4428061,J Med Chem,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3245818,=,1,1,=,,IC50,nM,,110610.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,110.61
45016,,,19432033,[],CHEMBL4429193,"Selectivity ratio, ratio of IC50 for cytosolic eukaryotic translation in rabbit reticulocyte S30 extract to IC50 for 16S rRNA A-site in Escherichia coli S30 extract",T,,,BAO_0000179,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4428061,J Med Chem,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3245818,=,1,0,=,,Ratio IC50,,,1106.1,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,1106.1
45017,,,19457696,[],CHEMBL4476986,Antimicrobial activity against Staphylococcus aureus ATCC 29213 incubated overnight under aerobic condition by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4476873,,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3252385,=,38,1,=,,MIC,nM,,1560.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,1.56
45018,,,19457756,[],CHEMBL4476987,Antimicrobial activity against Staphylococcus aureus NRS70 incubated overnight under aerobic condition by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4476873,,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3252385,=,38,1,=,,MIC,nM,,50000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,50.0
45019,,Not Determined,19457809,[],CHEMBL4476988,Antimicrobial activity against Staphylococcus aureus USA300 incubated overnight under aerobic condition by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4476873,,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3252385,,38,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
45020,,Not Determined,19457865,[],CHEMBL4476989,Antimicrobial activity against Staphylococcus aureus USA300 deficient in ClpP incubated overnight under aerobic condition by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4476873,,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3252385,,38,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
45021,,,19457921,[],CHEMBL4476990,Antimicrobial activity against Streptococcus pyogenes ATCC 700294 incubated overnight under aerobic condition by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4476873,,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3252385,=,38,1,=,,MIC,nM,,12500.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,uM,UO_0000065,,12.5
45022,,Not Determined,19457977,[],CHEMBL4476991,Antimicrobial activity against Streptococcus pneumoniae R6 incubated overnight under aerobic condition by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4476873,,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3252385,,38,0,,,MIC,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,,,,
45023,,,19458033,[],CHEMBL4476992,Antimicrobial activity against Streptococcus pneumoniae DAW27 incubated overnight under aerobic condition by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4476873,,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3252385,=,38,1,=,,MIC,nM,,25000.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,uM,UO_0000065,,25.0
45024,,,19458089,[],CHEMBL4476993,Antimicrobial activity against Bacillus subtilis ATCC 23857 incubated overnight under aerobic condition by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4476873,,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3252385,=,38,1,=,,MIC,nM,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,uM,UO_0000065,,0.1
45025,,,19458145,[],CHEMBL4476994,Antimicrobial activity against Enterococcus faecalis ATCC 33186 incubated overnight under aerobic condition by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4476873,,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3252385,=,38,1,=,,MIC,nM,,25000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,25.0
45026,,,19458201,[],CHEMBL4476995,Antimicrobial activity against Escherichia coli K-12 deficient in ClpP incubated overnight under aerobic condition by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4476873,,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3252385,=,38,1,=,,MIC,nM,,400.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,0.4
45027,,,19472700,[],CHEMBL4479000,"Drug activation in human Hep3B cells assessed as human CYP3A4-mediated drug metabolism-induced cytotoxicity measured as decrease in cell viability at 300 uM pre-incubated with BSO for 18 hrs followed by incubation with compound for 3 hrs in presence of NADPH measured after 24 hrs in absence of compound, CYP3A4 and NADPH by cell titer-glo luminescence assay relative to BSO alone",A,,,BAO_0000179,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4477225,Bioorg Med Chem Lett,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3256229,=,1,0,=,,FC,,,1.0,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,FC,,,,1.0
45028,,,19472879,[],CHEMBL4479083,"Drug activation in human Hep3B cells assessed as human CYP2D6-mediated drug metabolism-induced cytotoxicity measured as decrease in cell viability at 300 uM pre-incubated with BSO for 18 hrs followed by incubation with compound for 3 hrs in presence of NADPH measured after 24 hrs in absence of compound, CYP3A4 and NADPH by cell titer-glo luminescence assay relative to BSO alone",A,,,BAO_0000179,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4477225,Bioorg Med Chem Lett,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3256229,=,1,0,=,,FC,,,1.0,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,FC,,,,1.0
45029,,,19473008,[],CHEMBL4478999,"Drug activation in human Hep3B cells assessed as human CYP2C9-mediated drug metabolism-induced cytotoxicity measured as decrease in cell viability at 300 uM pre-incubated with BSO for 18 hrs followed by incubation with compound for 3 hrs in presence of NADPH measured after 24 hrs in absence of compound, CYP3A4 and NADPH by cell titer-glo luminescence assay relative to BSO alone",A,,,BAO_0000179,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4477225,Bioorg Med Chem Lett,2016.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3256229,=,1,0,=,,FC,,,1.0,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,FC,,,,1.0
45030,,,19486327,[],CHEMBL4481635,Antimicrobial activity against Bacillus subtilis at 0.5 to 256 ug/ml after 24 hrs by two-fold serial micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4480416,J Nat Prod,2019.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258819,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,4.0
45031,,,19486333,[],CHEMBL4481636,Antimicrobial activity against Escherichia coli at 0.5 to 256 ug/ml after 24 hrs by two-fold serial micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4480416,J Nat Prod,2019.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258819,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
45032,,,19486339,[],CHEMBL4481637,Antimicrobial activity against Staphylococcus aureus at 0.5 to 256 ug/ml after 24 hrs by two-fold serial micro dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4480416,J Nat Prod,2019.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3258819,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
45033,,,20644767,[],CHEMBL4613764,"Anti-leprotic activity against Mycobacterium leprae infected in BALB/c weanling mouse assessed as bacteria killing at 100 mg/kg, ip administrated for 60 days and measured after 1 year by most probable number technique analysis relative to control",F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4613212,Bioorg Med Chem,2019.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://qudt.org/vocab/unit#Percent,3474762,=,1,0,=,,Activity,%,,99.8,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,Activity,%,UO_0000187,,99.8
45034,,,20644773,[],CHEMBL4613959,"Anti-leprotic activity against Mycobacterium leprae infected in BALB/c weanling mouse assessed as bacteria killing at 100 mg/kg, ip administrated for 60 days and measured after 1 year by Spearman-Karber technique analysis relative to control",F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4613212,Bioorg Med Chem,2019.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://qudt.org/vocab/unit#Percent,3474762,=,1,0,=,,Activity,%,,99.7,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,Activity,%,UO_0000187,,99.7
45035,,,20659994,[],CHEMBL4618078,Antimicrobial activity against methicillin-resistant Staphylococcus aureus incubated for 7 hrs by alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4616652,J Nat Prod,2020.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3478510,>,1,1,>,,MIC,ug.mL-1,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,100.0
45036,,,20659998,[],CHEMBL4618079,Antimicrobial activity against Staphylococcus aureus incubated for 7 hrs by alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4616652,J Nat Prod,2020.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3478510,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.8
45037,,,20660002,[],CHEMBL4618080,Antimicrobial activity against Shigella dysenteriae incubated for 7 hrs by alamar Blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4616652,J Nat Prod,2020.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3478510,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,,MIC,ug ml-1,UO_0000274,,0.2
45038,,Not Determined,20686305,[],CHEMBL4624323,Antibacterial activity against methicillin-resistant Staphylococcus aureus shhs-A1 incubated for 16 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4622887,J Nat Prod,2020.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3483930,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
45039,,,20686326,[],CHEMBL4624324,Antibacterial activity against Staphylococcus aureus ATCC 6538 incubated for 16 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4622887,J Nat Prod,2020.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3483930,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.56
45040,,,20686347,[],CHEMBL4624325,Antibacterial activity against Bacillus subtilis ATCC 6633 incubated for 16 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4622887,J Nat Prod,2020.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3483930,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,,MIC,ug ml-1,UO_0000274,,0.78
45041,,,20686368,[],CHEMBL4624326,Antibacterial activity against Escherichia coli ATCC 8099 incubated for 16 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4622887,J Nat Prod,2020.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3483930,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,50.0
45042,,No. Measurements = 1,22084584,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4651402,,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3492646,>,57,1,>,,IC50,nM,,20000.0,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,IC50,M,UO_0000065,,2e-05
45043,,No. Measurements = 1,22084585,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4651402,,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3492646,<,57,1,>,,IC50,nM,,19952.62,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,pIC50,,UO_0000065,,4.7
45044,,,22401281,[],CHEMBL4669651,Antimicrobial activity against Mycobacterium smegmatis DSM44200 by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4665748,J Nat Prod,2020.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3509419,=,1,1,=,,MIC,ug.mL-1,,0.6,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.6
45045,,,22446488,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL4679649,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth incubated for 16 to 20 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4673388,ACS Med Chem Lett,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3517993,>,1,1,>,,MIC,nM,,128000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,128.0
45046,,,22755501,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4700681,Antibacterial activity against Staphylococcus aureus ATCC 29737 incubated for 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4699440,Eur J Med Chem,2019.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532061,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
45047,,,22755515,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4700682,Antibacterial activity against Micrococcus Luteus ATCC 398 incubated for 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4699440,Eur J Med Chem,2019.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532061,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,2.0
45048,,,22755529,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4700683,Antibacterial activity against Bacillus cereus ATCC 6630 incubated for 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4699440,Eur J Med Chem,2019.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532061,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,2.0
45049,,,22755543,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4700684,Antibacterial activity against Escherichia coli NCIM 2256 incubated for 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4699440,Eur J Med Chem,2019.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532061,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
45050,,,22755557,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4700685,Antibacterial activity against Pseudomonas fluorescens NCIM 2173 incubated for 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4699440,Eur J Med Chem,2019.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532061,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,,MIC,ug ml-1,UO_0000274,,2.0
45051,,,22755571,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4700686,Antibacterial activity against Flavobacterium devorans ATCC 10829 incubated for 24 hrs,F,,,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4699440,Eur J Med Chem,2019.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532061,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,2.0
45052,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22818839,[],CHEMBL4715937,Displacement of F-neo from premature miRNA21 (unknown origin) by fluorescence assay,B,,,BAO_0000190,BAO_0000225,nucleic acid format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4715681,Medchemcomm,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,5.96,0,http://www.openphacts.org/units/Nanomolar,3544477,=,1,1,=,,IC50,nM,,1102.0,CHEMBL1615322,Homo sapiens,microRNA 21,9606.0,,,IC50,nM,UO_0000065,,1102.0
45053,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22818845,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'nM', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'nM', 'value': '100.0'}]",CHEMBL4715938,Displacement of F-neo from premature miRNA21 (unknown origin) at 100 nM by fluorescence assay relative to control,B,,,BAO_0000201,BAO_0000225,nucleic acid format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4715681,Medchemcomm,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://qudt.org/vocab/unit#Percent,3544477,=,1,1,=,,Inhibition,%,,100.0,CHEMBL1615322,Homo sapiens,microRNA 21,9606.0,,,INH,%,UO_0000187,,100.0
45054,,Not Active,22818859,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '5.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '5.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4715943,Antiproliferative activity against human MCF7 cells assessed as reduction in Ki67 expression at 5 uM incubated for 48 hrs by fluorescence microscopy,F,,,BAO_0000201,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4715681,Medchemcomm,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://qudt.org/vocab/unit#Percent,3544477,,1,0,,,Inhibition,%,,,CHEMBL387,Homo sapiens,MCF7,9606.0,,,INH,,UO_0000187,,
45055,,,22818862,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '15.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '15.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL4715946,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth incubated for 15 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4715681,Medchemcomm,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3544477,=,1,1,=,,MIC,nM,,4000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,4.0
45056,,,22818863,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '15.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '15.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL4715947,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction in bacterial growth incubated for 15 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4715681,Medchemcomm,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3544477,=,1,1,=,,MIC,nM,,4000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,4.0
45057,,,22818864,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '15.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '15.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL4715948,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as reduction in bacterial growth incubated for 15 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4715681,Medchemcomm,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3544477,>,1,1,>,,MIC,nM,,256000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,256.0
45058,,,22818865,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '15.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '15.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL4715949,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 1960649 assessed as reduction in bacterial growth incubated for 15 to 20 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4715681,Medchemcomm,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3544477,>,1,1,>,,MIC,nM,,256000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,256.0
45059,,,22818872,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '64.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '64.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '15.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '15.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL4715950,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial growth at 64 uM incubated for 15 to 20 hrs by broth microdilution method relative to control,F,,,BAO_0000096,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4715681,Medchemcomm,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://qudt.org/vocab/unit#Percent,3544477,=,1,0,=,,GI,%,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,GI,%,UO_0000187,,100.0
45060,,,22818879,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '64.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '64.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '15.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '15.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL4715951,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction in bacterial growth at 64 uM incubated for 15 to 20 hrs by broth microdilution method relative to control,F,,,BAO_0000096,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4715681,Medchemcomm,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://qudt.org/vocab/unit#Percent,3544477,=,1,0,=,,GI,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,GI,%,UO_0000187,,100.0
45061,,,22818886,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '64.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '64.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '15.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '15.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL4715952,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as reduction in bacterial growth at 64 uM incubated for 15 to 20 hrs by broth microdilution method relative to control,F,,,BAO_0000096,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4715681,Medchemcomm,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://qudt.org/vocab/unit#Percent,3544477,=,1,0,=,,GI,%,,11.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,GI,%,UO_0000187,,11.0
45062,,,22818893,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '64.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '64.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '15.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '15.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL4715953,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 1960649 assessed as reduction in bacterial growth at 64 uM incubated for 15 to 20 hrs by broth microdilution method relative to control,F,,,BAO_0000096,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4715681,Medchemcomm,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://qudt.org/vocab/unit#Percent,3544477,=,1,0,=,,GI,%,,41.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,GI,%,UO_0000187,,41.0
45063,,,22922697,[],CHEMBL4736919,Antitubercular activity against drug susceptible Mycobacterium tuberculosis V4207 by MABA assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4732169,Eur J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3559050,=,1,0,=,,MIC=<90,ug ml-1,,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC=<90,ug ml-1,UO_0000274,,2.0
45064,,,22922703,[],CHEMBL4736920,Antitubercular activity against multi drug resistance Mycobacterium tuberculosis V2475 by MABA assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4732169,Eur J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3559050,=,1,0,=,,MIC=<90,ug ml-1,,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC=<90,ug ml-1,UO_0000274,,2.0
45065,,,22922709,[],CHEMBL4736921,Antitubercular activity against isoniazid/rifampin resistance Mycobacterium tuberculosis KZN494 by MABA assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4732169,Eur J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3559050,=,1,0,=,,MIC=<90,ug ml-1,,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC=<90,ug ml-1,UO_0000274,,2.0
45066,,,22922715,[],CHEMBL4736922,Antitubercular activity against isoniazid/rifampin/levofloxacin/ofloxacin/kanamycin extensively drug resistance Mycobacterium tuberculosis TF274 XDR by MABA assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4732169,Eur J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3559050,>,1,0,>,,MIC=<90,ug ml-1,,128.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC=<90,ug ml-1,UO_0000274,,128.0
45067,,,22922721,[],CHEMBL4736923,Antitubercular activity against extensively drug resistance Mycobacterium tuberculosis R506 XDR by MABA,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4732169,Eur J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3559050,>,1,0,>,,MIC=<90,ug ml-1,,128.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC=<90,ug ml-1,UO_0000274,,128.0
45068,,,22922737,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4736926,Antibacterial activity against Staphylococcus aureus Newman assessed as inhibition of bacterial growth measured after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4732169,Eur J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3559050,=,1,1,=,,MIC,ug.mL-1,,2.34,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.34
45069,,,22922741,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4736927,Antibacterial activity against Bacillus subtilis168 assessed as inhibition of bacterial growth measured after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4732169,Eur J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3559050,=,1,1,=,,MIC,ug.mL-1,,9.39,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,9.39
45070,,,22922745,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4736928,Antibacterial activity against Escherichia coli AB1157 assessed as inhibition of bacterial growth measured after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4732169,Eur J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3559050,=,1,1,=,,MIC,ug.mL-1,,9.39,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,9.39
45071,,,22922749,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4736929,Antibacterial activity against Escherichia coli DH5-alpha assessed as inhibition of bacterial growth measured after 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4732169,Eur J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3559050,=,1,1,=,,MIC,ug.mL-1,,2.34,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.34
45072,,,22966915,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4769719,Antibacterial activity against Staphylococcus aureus Newman strain assessed as reduction in bacterial growth incubated for 16 to 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4765312,Eur J Med Chem,2020.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566388,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.13
45073,,,22966943,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4769720,Antibacterial activity against multidrug-resistant Staphylococcus aureus NRS1 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4765312,Eur J Med Chem,2020.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566388,>,1,1,>,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
45074,,,22966952,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4769721,Antibacterial activity against multidrug-resistant Staphylococcus aureus NRS70 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4765312,Eur J Med Chem,2020.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566388,>,1,1,>,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
45075,,,22966963,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4769722,Antibacterial activity against mutidrug-resistant Staphylococcus aureus NRS100 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4765312,Eur J Med Chem,2020.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566388,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.56
45076,,,22966971,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4769723,Antibacterial activity against multidrug-resistant Staphylococcus aureus NRS108 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4765312,Eur J Med Chem,2020.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566388,>,1,1,>,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
45077,,,22966979,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4769724,Antibacterial activity against multidrug-resistant Staphylococcus aureus NRS271 assessed as reduction in bacterial growth incubated for 16 to 18 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4765312,Eur J Med Chem,2020.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3566388,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.13
45078,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22978460,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4772323,Inhibition of human Cx43 expressed in Escherichia coli LB2003 cells in medium containing 8 mM K+ and 10 uM IPTG by measuring cell growth after 18 hrs by plate reader,B,,,BAO_0000190,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4765383,Eur J Med Chem,2020.0,"{'bei': '8.91', 'le': '0.18', 'lle': '11.61', 'sei': '1.53'}",CHEMBL1384,KANAMYCIN,CHEMBL1384,4.32,0,http://www.openphacts.org/units/Nanomolar,3568479,=,1,1,=,,IC50,nM,,48000.0,CHEMBL4680024,Homo sapiens,Gap junction alpha-1 protein,9606.0,,,IC50,uM,UO_0000065,,48.0
45079,,,22978473,[],CHEMBL4772324,Selectivity ratio of IC50 for inhibition of human Cx43 to IC50 for inhibition of human Cx26,B,,,BAO_0002136,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4765383,Eur J Med Chem,2020.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3568479,=,1,0,=,,Selectivity ratio,,,0.24,CHEMBL612545,,Unchecked,,,,Selectivity ratio,,,,0.24
45080,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22978480,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4772325,Inhibition of human Cx26 expressed in Escherichia coli LB2003 cells in medium containing 4 mM K+ and 500 uM IPTG by measuring cell growth after 18 hrs by plate reader,B,,,BAO_0000190,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4765383,Eur J Med Chem,2020.0,"{'bei': '10.19', 'le': '0.20', 'lle': '12.23', 'sei': '1.75'}",CHEMBL1384,KANAMYCIN,CHEMBL1384,4.94,0,http://www.openphacts.org/units/Nanomolar,3568479,=,1,1,=,,IC50,nM,,11500.0,CHEMBL4295738,Homo sapiens,Gap junction beta-2 protein,9606.0,,,IC50,uM,UO_0000065,,11.5
45081,,,23221075,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4824662,Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 18 hrs by CLSI based broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4823282,J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3611771,<,1,1,<,,MIC,nM,,1000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,1.0
45082,,,23221111,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4824663,Antibacterial activity against Bacillus subtilis ATCC 23857 incubated for 18 hrs by CLSI based broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4823282,J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3611771,<,1,1,<,,MIC,nM,,1000.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,uM,UO_0000065,,1.0
45083,,,23221147,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4824664,Antibacterial activity against Enterococcus faecalis ATCC 29212 incubated for 18 hrs by CLSI based broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4823282,J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3611771,=,1,1,=,,MIC,nM,,8000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,8.0
45084,,,23221183,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4824665,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 incubated for 18 hrs by CLSI based broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4823282,J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3611771,<,1,1,<,,MIC,nM,,1000.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,uM,UO_0000065,,1.0
45085,,,23221219,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4824666,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 18 hrs by CLSI based broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4823282,J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3611771,=,1,1,=,,MIC,nM,,8000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,8.0
45086,,,23221255,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4824667,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 18 hrs by CLSI based broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4823282,J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3611771,=,1,1,=,,MIC,nM,,8000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,8.0
45087,,,23221291,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4824668,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 incubated for 18 hrs by CLSI based broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4823282,J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3611771,=,1,1,=,,MIC,nM,,32000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,uM,UO_0000065,,32.0
45088,,,23221327,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4824669,Antibacterial activity against Acinetobacter baumannii ATCC 19606 incubated for 18 hrs by CLSI based broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL4823282,J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3611771,=,1,1,=,,MIC,nM,,4000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,4.0
45089,,,24377709,[],CHEMBL5037640,Antibacterial activity against Escherichia coli ATCC25922 assessed as reduction in bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5036339,Eur J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776623,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,6.25
45090,,,24505016,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5054063,Antibacterial activity against Bacillus subtilis E168 assessed as bacterial growth inhibition measured after 16 to 20 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5053506,J Nat Prod,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3836799,<,1,1,<,,MIC,ug.mL-1,,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,2.0
45091,,,24505020,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5054064,Antibacterial activity against TolC deficient Escherichia coli assessed as bacterial growth inhibition measured after 16 to 20 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5053506,J Nat Prod,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3836799,<,1,1,<,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
45092,,,24505028,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5054066,Antibacterial activity against Staphylococcus aureus assessed as bacterial growth inhibition measured after 16 to 20 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5053506,J Nat Prod,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3836799,<,1,1,<,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
45093,,,24700559,[],CHEMBL5107476,Antibacterial activity against wild type Escherichia coli ATCC 25922 assessed as bacterial growth inhibition by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5104205,RSC Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3851609,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
45094,,,24700585,[],CHEMBL5107482,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 assessed as bacterial growth inhibition by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5104205,RSC Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3851609,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
45095,,,24700696,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '840.0', 'text_value': None, 'type': 'Time', 'units': 'weeks', 'value': '5.0'}]",CHEMBL5107501,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth for 5 weeks by spot culture growth inhibition assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5104207,RSC Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3851657,=,1,1,=,,MIC90,nM,,16100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,16.1
45096,,,24733434,[],CHEMBL5116261,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis assessed as mycobacterial growth inhibition,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5113423,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3858163,=,1,1,=,,MIC50,ug.mL-1,,1.235,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,ug ml-1,UO_0000274,,1.235
45097,,,24733440,[],CHEMBL5116261,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis assessed as mycobacterial growth inhibition,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5113423,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3858163,>,1,1,>,,MIC90,ug.mL-1,,40.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,40.0
45098,,,24733446,[],CHEMBL5116262,Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis assessed as mycobacterial growth inhibition,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5113423,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3858163,=,1,1,=,,MIC50,ug.mL-1,,1.219,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,ug ml-1,UO_0000274,,1.219
45099,,,24733452,[],CHEMBL5116262,Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis assessed as mycobacterial growth inhibition,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5113423,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3858163,=,1,1,=,,MIC90,ug.mL-1,,1.907,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,1.907
45100,,,24737358,[],CHEMBL5117270,Antimycobacterial activity against clinical isolate multidrug resistant Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5113463,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3858901,=,1,1,=,,MIC50,ug.mL-1,,1.235,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,ug ml-1,UO_0000274,,1.235
45101,,,24737359,[],CHEMBL5117270,Antimycobacterial activity against clinical isolate multidrug resistant Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5113463,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3858901,>,1,1,>,,MIC90,ug.mL-1,,40.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,40.0
45102,,,24737370,[],CHEMBL5117271,Antimycobacterial activity against clinical isolate drug susceptible Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5113463,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3858901,=,1,1,=,,MIC50,ug.mL-1,,1.219,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,ug ml-1,UO_0000274,,1.219
45103,,,24737371,[],CHEMBL5117271,Antimycobacterial activity against clinical isolate drug susceptible Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5113463,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3858901,=,1,1,=,,MIC90,ug.mL-1,,1.907,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,1.907
45104,,,24752752,[],CHEMBL5121459,Antibacterial activity against Mycobacterium smegmatis ATCC 700084 assessed as inhibition of bacterial growth incubated for overnight by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120760,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3861692,=,1,1,=,,MIC,ug.mL-1,,1.7,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,1.7
45105,,,24754540,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5122123,Antifungal activity against Bacillus subtilis assessed as reduction in microbial growth after 24 hrs by two-fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120790,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862090,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.0
45106,,,24754550,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5122124,Antifungal activity against Escherichia coli assessed as reduction in microbial growth after 24 hrs by two-fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120790,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862090,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
45107,,,24754560,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5122125,Antifungal activity against Staphylococcus aureus assessed as reduction in microbial growth after 24 hrs by two-fold dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120790,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862090,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
45108,,,24759653,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5123408,Antibacterial activity against Staphylococcus aureus ATCC 9144 assessed as inhibition of visible bacterial growth incubated for 18 hrs by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120847,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862992,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
45109,,,24759659,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5123409,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as inhibition of visible bacterial growth incubated for 18 hrs by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120847,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862992,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
45110,,,24759665,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5123410,Antibacterial activity against Bacillus cereus ATCC 11778 assessed as inhibition of visible bacterial growth incubated for 18 hrs by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120847,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862992,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,2.0
45111,,,24759671,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5123411,Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as inhibition of visible bacterial growth incubated for 18 hrs by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120847,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862992,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.5
45112,,,24759677,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5123412,Antibacterial activity against Micrococcus luteus ATCC 9341 assessed as inhibition of visible bacterial growth incubated for 18 hrs by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120847,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862992,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,8.0
45113,,,24759683,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5123413,Antibacterial activity against Listeria monocytogenes ATCC19111 assessed as inhibition of visible bacterial growth incubated for 18 hrs by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120847,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862992,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,1.0
45114,,,24759689,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5123414,Antibacterial activity against Mycobacterium smegmatis ATCC 607 assessed as inhibition of visible bacterial growth incubated for 48 hrs by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120847,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862992,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.25
45115,,,24759695,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5123415,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate 3B assessed as inhibition of visible bacterial growth incubated for 18 hrs by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120847,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862992,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
45116,,,24759701,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5123416,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate 6B assessed as inhibition of visible bacterial growth incubated for 18 hrs by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120847,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862992,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
45117,,,24759707,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5123417,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate 9B assessed as inhibition of visible bacterial growth incubated for 18 hrs by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120847,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862992,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
45118,,,24759713,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5123418,Antibacterial activity against methicillin-resistant Staphylococcus aureus clinical isolate 10B assessed as inhibition of visible bacterial growth incubated for 18 hrs by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120847,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862992,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
45119,,,24759719,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5123419,Antibacterial activity against Escherichia coli ATCC 8739 assessed as inhibition of visible bacterial growth incubated for 18 hrs by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120847,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862992,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
45120,,,24759725,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5123420,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 assessed as inhibition of visible bacterial growth incubated for 18 hrs by CLSI protocol based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120847,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3862992,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
45121,,,24765046,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124870,Antibacterial activity against Mycobacterium phlei DSM 43239 assessed as reduction in bacterial growth measured after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864143,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614985,Mycolicibacterium phlei,Mycolicibacterium phlei,1771.0,,,MIC,ug ml-1,UO_0000274,,1.0
45122,,,24765047,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124871,Bactericidal activity against Mycobacterium phlei DSM 43239 assessed as reduction in colony count and measured after 3 days by agar diffusion assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864143,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL614985,Mycolicibacterium phlei,Mycolicibacterium phlei,1771.0,,,MBC,ug ml-1,UO_0000274,,1.0
45123,,,24765050,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124872,Antibacterial activity against Mycobacterium smegmatis DSM 43080 assessed as reduction in bacterial growth measured after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864143,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.5
45124,,,24765053,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124873,Bactericidal activity against Mycobacterium smegmatis DSM 43080 assessed as reduction in colony count and measured after 3 days by agar diffusion assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864143,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MBC,ug ml-1,UO_0000274,,0.5
45125,,,24765056,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124874,Antibacterial activity against Bacillus cereus DSM 31 assessed as reduction in bacterial growth measured after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864143,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,8.0
45126,,ND,24765059,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124875,Bactericidal activity against Bacillus cereus DSM 31 assessed as reduction in colony count and measured after 3 days by agar diffusion assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3864143,,1,0,,,MBC,,,,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MBC,,,,
45127,,,24765063,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124876,Antibacterial activity against Enterococcus faecium DSM 20477 assessed as reduction in bacterial growth measured after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864143,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,32.0
45128,,,24765065,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124877,Bactericidal activity against Enterococcus faecium DSM 20477 assessed as reduction in colony count and measured after 3 days by agar diffusion assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864143,>,1,0,>,,MBC,ug ml-1,,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MBC,ug ml-1,UO_0000274,,32.0
45129,,,24765068,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124878,Antibacterial activity against Staphylococcus aureus DSM 20231 assessed as reduction in bacterial growth measured after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864143,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
45130,,ND,24765071,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124879,Bactericidal activity against Staphylococcus aureus DSM 20231 assessed as reduction in colony count and measured after 3 days by agar diffusion assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3864143,,1,0,,,MBC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,,,,
45131,,,24765074,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124880,Antibacterial activity against Klebsiella oxytoca DSM 5175 assessed as reduction in bacterial growth measured after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864143,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,2.0
45132,,ND,24765077,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124881,Bactericidal activity against Klebsiella oxytoca DSM 5175 assessed as reduction in colony count and measured after 3 days by agar diffusion assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3864143,,1,0,,,MBC,,,,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MBC,,,,
45133,,,24765080,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124882,Antibacterial activity against Acinetobacter baumannii DSM 300007 assessed as reduction in bacterial growth measured after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864143,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,2.0
45134,,ND,24765083,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124883,Bactericidal activity against Acinetobacter baumannii DSM 300007 assessed as reduction in colony count and measured after 3 days by agar diffusion assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3864143,,1,0,,,MBC,,,,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MBC,,,,
45135,,,24765086,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124884,Antibacterial activity against Pseudomonas aeruginosa DSM 19880 assessed as reduction in bacterial growth measured after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864143,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
45136,,,24765089,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124885,Bactericidal activity against Pseudomonas aeruginosa DSM 19880 assessed as reduction in colony count and measured after 3 days by agar diffusion assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864143,>,1,0,>,,MBC,ug ml-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,ug ml-1,UO_0000274,,32.0
45137,,,24765092,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124886,Antibacterial activity against Enterobacter cloacae DSM 30054 assessed as reduction in bacterial growth measured after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864143,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,2.0
45138,,ND,24765095,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5124887,Bactericidal activity against Enterobacter cloacae DSM 30054 assessed as reduction in colony count and measured after 3 days by agar diffusion assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5120907,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3864143,,1,0,,,MBC,,,,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MBC,,,,
45139,,,24800204,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5134763,Antibacterial activity against pET28a-NDM-1 positive Escherichia coli BL21(DE3) isolates assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5131475,Eur J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871474,=,1,1,=,,MIC,ug.mL-1,,0.512,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug/L,UO_0000274,,512.0
45140,,,24800219,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '24.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5134764,Antibacterial activity against NDM-1 positive Escherichia coli ZC-YN3 isolates assessed as inhibition of bacterial growth incubated for 18 to 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5131475,Eur J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871474,=,1,1,=,,MIC,ug.mL-1,,0.8533,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug/L,UO_0000274,,853.33
45141,,Active,24816468,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '40.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '40.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5138736,Antibacterial activity against Escherichia coli K12 expressing modified luxABCDE genes assessed as reduction in bacterial growth by measuring reduction in optical density at 40 uM incubated for 16 hrs by microplate reader analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5137012,Eur J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3875295,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
45142,,Active,24816470,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '40.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '40.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5138737,Antibacterial activity against Escherichia coli K12 expressing modified luxABCDE genes assessed as reduction in bacterial growth by measuring reduction in bioluminescence at 40 uM incubated for 16 hrs by microplate reader analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5137012,Eur J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3875295,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
45143,,,24832520,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5143171,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth incubated for 24 hrs by optical density based analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5137119,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878403,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
45144,,,24832526,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5143172,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth incubated for 24 hrs by optical density based analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5137119,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878403,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
45145,,,24832532,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5143173,Antibacterial activity against Staphylococcus epidermidis ATCC 51625 assessed as inhibition of bacterial growth incubated for 24 hrs by optical density based analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5137119,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878403,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
45146,,,24832538,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5143174,Antibacterial activity against Bacillus subtilis ATCC 11774 assessed as inhibition of bacterial growth incubated for 24 hrs by optical density based analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5137119,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3878403,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,2.0
45147,,,24847123,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'day', 'standard_value': '3.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'day', 'value': '3.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'day', 'standard_value': '5.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'day', 'value': '5.0'}]",CHEMBL5146976,Antimycobacterial activity against wild type Mycobacterium smegmatis mc2 155 assessed as inhibition of mycobacterial growth incubated for 3 to 5 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5143637,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881315,=,1,1,=,,MIC90,ug.mL-1,,0.94,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC90,ug ml-1,UO_0000274,,0.94
45148,,,24847128,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'day', 'standard_value': '3.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'day', 'value': '3.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'day', 'standard_value': '5.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'day', 'value': '5.0'}]",CHEMBL5146976,Antimycobacterial activity against wild type Mycobacterium smegmatis mc2 155 assessed as inhibition of mycobacterial growth incubated for 3 to 5 days by resazurin microtiter assay,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5143637,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881315,=,1,1,=,,MIC50,ug.mL-1,,0.4,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC50,ug ml-1,UO_0000274,,0.4
45149,,,24847133,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'day', 'standard_value': '3.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'day', 'value': '3.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'day', 'standard_value': '5.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'day', 'value': '5.0'}]",CHEMBL5146977,Antimycobacterial activity against Mycobacterium smegmatis mc2 155 harbouring pMyC empty vector assessed as inhibition of mycobacterial growth incubated for 3 to 5 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5143637,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881315,=,1,1,=,,MIC90,ug.mL-1,,1.07,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC90,ug ml-1,UO_0000274,,1.07
45150,,,24847138,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'day', 'standard_value': '3.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'day', 'value': '3.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'day', 'standard_value': '5.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'day', 'value': '5.0'}]",CHEMBL5146977,Antimycobacterial activity against Mycobacterium smegmatis mc2 155 harbouring pMyC empty vector assessed as inhibition of mycobacterial growth incubated for 3 to 5 days by resazurin microtiter assay,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5143637,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881315,=,1,1,=,,MIC50,ug.mL-1,,0.48,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC50,ug ml-1,UO_0000274,,0.48
45151,,,24847143,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'day', 'standard_value': '3.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'day', 'value': '3.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'day', 'standard_value': '5.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'day', 'value': '5.0'}]",CHEMBL5146978,Antimycobacterial activity against Mycobacterium smegmatis mc2 155 harbouring pMyC::PDFMtb overexpression mutant assessed as inhibition of mycobacterial growth incubated for 3 to 5 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5143637,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881315,=,1,1,=,,MIC90,ug.mL-1,,0.87,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC90,ug ml-1,UO_0000274,,0.87
45152,,,24847148,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'day', 'standard_value': '3.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'day', 'value': '3.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'day', 'standard_value': '5.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'day', 'value': '5.0'}]",CHEMBL5146978,Antimycobacterial activity against Mycobacterium smegmatis mc2 155 harbouring pMyC::PDFMtb overexpression mutant assessed as inhibition of mycobacterial growth incubated for 3 to 5 days by resazurin microtiter assay,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5143637,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881315,=,1,1,=,,MIC50,ug.mL-1,,0.49,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC50,ug ml-1,UO_0000274,,0.49
45153,,,24847153,[],CHEMBL5146979,"Selectivity index, ratio of MIC50 for antimycobacterial activity against Mycobacterium smegmatis mc2 155 harbouring pMyC empty vector to MIC50 for antimycobacterial activity against wild type Mycobacterium smegmatis mc2 155",F,,,BAO_0000193,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5143637,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3881315,=,1,0,=,,Ratio,,,1.2,CHEMBL612545,,Unchecked,,,,Ratio,,,,1.2
45154,,,24847158,[],CHEMBL5146980,"Selectivity index, ratio of MIC90 for antimycobacterial activity against Mycobacterium smegmatis mc2 155 harbouring pMyC empty vector to MIC90 for antimycobacterial activity against wild type Mycobacterium smegmatis mc2 155",F,,,BAO_0000193,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5143637,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3881315,=,1,0,=,,Ratio,,,1.14,CHEMBL612545,,Unchecked,,,,Ratio,,,,1.14
45155,,,24847163,[],CHEMBL5146981,"Selectivity index, ratio of MIC50 for antimycobacterial activity against Mycobacterium smegmatis mc2 155 harbouring pMyC::PDFMtb overexpression mutant to MIC50 for antimycobacterial activity against wild type Mycobacterium smegmatis mc2 155",F,,,BAO_0000193,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5143637,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3881315,=,1,0,=,,Ratio,,,1.23,CHEMBL612545,,Unchecked,,,,Ratio,,,,1.23
45156,,,24847168,[],CHEMBL5146982,"Selectivity index, ratio of MIC90 for antimycobacterial activity against Mycobacterium smegmatis mc2 155 harbouring pMyC::PDFMtb overexpression mutant to MIC90 for antimycobacterial activity against wild type Mycobacterium smegmatis mc2 155",F,,,BAO_0000193,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5143637,Bioorg Med Chem Lett,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3881315,=,1,0,=,,Ratio,,,0.93,CHEMBL612545,,Unchecked,,,,Ratio,,,,0.93
45157,,,24847576,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5147052,Antimicrobial activity against Bacillus subtilis ATCC 23857 assessed as inhibition of microbial growth incubated for 16 hrs under shaking condition by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5143641,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881381,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.8
45158,,,24847590,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5147053,Antimicrobial activity against Staphylococcus aureus ATCC 51650 assessed as inhibition of microbial growth incubated for 16 hrs under shaking condition by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5143641,J Nat Prod,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881381,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.6
45159,,,24906984,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5162137,Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as reduction of bacterial growth incubated for 18 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5154808,J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3892711,<,1,1,<,,MIC,nM,,1000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,1.0
45160,,,24907006,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5162138,Antimicrobial activity against Bacillus subtilis ATCC 23857 assessed as reduction of bacterial growth incubated for 18 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5154808,J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3892711,<,1,1,<,,MIC,nM,,1000.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,uM,UO_0000065,,1.0
45161,,,24907028,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5162139,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 assessed as reduction of bacterial growth incubated for 18 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5154808,J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3892711,>,1,1,>,,MIC,nM,,128000.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,uM,UO_0000065,,128.0
45162,,,24907050,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5162140,Antimicrobial activity against Enterococcus faecalis ATCC 29212 assessed as reduction of bacterial growth incubated for 18 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5154808,J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3892711,=,1,1,=,,MIC,nM,,16000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,16.0
45163,,,24907072,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5162141,Antimicrobial activity against Klebsiella pneumoniae ATCC 700603 assessed as reduction of bacterial growth incubated for 18 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5154808,J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3892711,=,1,1,=,,MIC,nM,,64000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,uM,UO_0000065,,64.0
45164,,,24907094,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5162142,Antimicrobial activity against Escherichia coli ATCC 25922 assessed as reduction of bacterial growth incubated for 18 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5154808,J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3892711,=,1,1,=,,MIC,nM,,4000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,4.0
45165,,,24907116,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5162143,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 assessed as reduction of bacterial growth incubated for 18 hrs by CLSI protocol based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5154808,J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3892711,>,1,1,>,,MIC,nM,,128000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,128.0
45166,,,24907209,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5162182,Induction of drug resistance in Staphylococcus aureus ATCC 25923 assessed as fold increase in MIC after 5 passages by CLSI protocol based broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5154808,J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3892711,=,1,0,=,,FC,,,64.0,CHEMBL612545,,Unchecked,,,,FC,,,,64.0
45167,,Active,24907217,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5162185,Induction of drug resistance in Escherichia coli ATCC 25922 assessed as increase in MIC measured after 20 passages by CLSI protocol based broth microdilution method,F,,,BAO_0000375,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5154808,J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,3892711,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
45168,,,24907232,[],CHEMBL5162190,Antimicrobial activity against kanamycin-resistant Staphylococcus aureus ATCC 25923,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5154808,J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3892711,=,1,1,=,,MIC,nM,,1024000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,1024.0
45169,,,24907235,[],CHEMBL5162191,Antimicrobial activity against kanamycin-resistant Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5154808,J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3892711,=,1,1,=,,MIC,nM,,1024000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,1024.0
45170,,,24909969,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5162990,Antibacterial activity against Methicillin resistant Staphylococcus aureus ATCC BAA -1556 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5154823,Eur J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893132,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
45171,,,24909982,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5162991,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5154823,Eur J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893132,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
45172,,,24909999,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5162993,Antibacterial activity against imipenem resistant Klebsiella pneumoniae ATCC BAA 1705 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5154823,Eur J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893132,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
45173,,,24910012,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5162994,Antibacterial activity against Pseudomonas aeruginosa ATCC 27883 assessed as reduction in microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5154823,Eur J Med Chem,2022.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893132,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
45174,,,24983318,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '8.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '8.0'}]",CHEMBL5226732,Antibacterial activity against Escherichia coli NCIM 2688 measured after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905436,=,1,1,=,,MIC90,ug.mL-1,,1.62,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,1.62
45175,,,24983325,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '8.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '8.0'}]",CHEMBL5226733,Antibacterial activity against Pseudomonas aeruginosa NCIM 2688 measured after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905436,=,1,1,=,,MIC90,ug.mL-1,,0.49,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,0.49
45176,,,24983332,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '12.0'}]",CHEMBL5226734,Antibacterial activity against Bacillus subtilis NCIM 2079 measured after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905436,=,1,1,=,,MIC90,ug.mL-1,,1.35,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC90,ug ml-1,UO_0000274,,1.35
45177,,,24983339,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '12.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '12.0'}]",CHEMBL5226735,Antibacterial activity against Staphylococcus aureus NCIM 2010 measured after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905436,>,1,1,>,,MIC90,ug.mL-1,,30.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,30.0
45178,,,25003368,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'microM', 'standard_value': '5.0', 'text_value': None, 'type': 'DOSE', 'units': 'microM', 'value': '5.0'}]",CHEMBL5233815,Inhibition of miR-27a (unknown origin) maturation at 5 uM relative to control,B,,,BAO_0000201,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5233220,Eur J Med Chem,2020.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://qudt.org/vocab/unit#Percent,3911856,=,1,1,=,,Inhibition,%,,25.0,CHEMBL612545,,Unchecked,,,,INH,%,UO_0000187,,25.0
45179,,,25010831,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5236515,Antibacterial activity against Bacillus subtilis E168 assessed as inhibition of bacterial growth incubated for 18 hrs by 2-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5233290,J Nat Prod,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3914500,<,1,1,<,,MIC,nM,,2000.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,uM,UO_0000065,,2.0
45180,,,25010840,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5236516,Antibacterial activity against Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth incubated for 18 hrs by 2-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5233290,J Nat Prod,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3914500,<,1,1,<,,MIC,nM,,2000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,2.0
45181,,,25010849,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5236517,Antibacterial activity against Staphylococcus epidermidis ATCC12228 assessed as inhibition of bacterial growth incubated for 18 hrs by 2-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5233290,J Nat Prod,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3914500,<,1,1,<,,MIC,nM,,2000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,2.0
45182,,,25010858,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5236518,Antibacterial activity against Escherichia coli ATCC35218 assessed as inhibition of bacterial growth incubated for 18 hrs by 2-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5233290,J Nat Prod,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3914500,<,1,1,<,,MIC,nM,,2000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,2.0
45183,,,25078161,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5255038,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth incubated for 16 to 20 hrs by Mueller-Hinton broth based two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5252576,J Nat Prod,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3931094,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
45184,,,25078163,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5255039,Antibacterial activity against Bacillus subtilis E168 assessed as inhibition of bacterial growth incubated for 16 to 20 hrs by Mueller-Hinton broth based two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5252576,J Nat Prod,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3931094,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,2.0
45185,,,25078165,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5255040,Antibacterial activity against TolC-deficient Escherichia coli assessed as inhibition of bacterial growth incubated for 16 to 20 hrs by Mueller-Hinton broth based two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5252576,J Nat Prod,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3931094,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
45186,,,25095378,[],CHEMBL5259867,Antimicrobial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5257111,RSC Med Chem,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3934992,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
45187,,,25096845,[],CHEMBL5260249,Antibacterial activity against Mycolicibacterium smegmatis assessed as bacterial growth inhibition by paper disc diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5257127,Bioorg Med Chem Lett,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3935395,=,1,1,=,,MIC,nM,,1600.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,uM,UO_0000065,,1.6
45188,,,25096850,[],CHEMBL5260250,Antibacterial activity against Micrococcus luteus assessed as bacterial growth inhibition by paper disc diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5257127,Bioorg Med Chem Lett,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3935395,=,1,1,=,,MIC,nM,,12800.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,uM,UO_0000065,,12.8
45189,,,25096855,[],CHEMBL5260251,Antibacterial activity against Staphylococcus aureus assessed as bacterial growth inhibition by paper disc diffusion assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5257127,Bioorg Med Chem Lett,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3935395,=,1,1,=,,MIC,nM,,200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.2
45190,,,25103804,[],CHEMBL5262786,Antimycobacterial activity against Mycobacterium tuberculosis harbouring rrs gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5260811,Eur J Med Chem,2017.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936456,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,1.0
45191,,,25106210,[],CHEMBL5263347,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5260825,J Nat Prod,2018.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://qudt.org/vocab/unit#Millimeter,3937410,=,1,1,=,,IZ,mm,,23.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,23.0
45192,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25118354,[],CHEMBL5291828,"Compound was evaluated for inhibition of human KCNH2 in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,AC50,uM,UO_0000065,,30.0
45193,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25119863,[],CHEMBL5291755,Compound was evaluated for inhibition of rat Cacna1c in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL3762,Rattus norvegicus,Voltage-gated L-type calcium channel alpha-1C subunit,10116.0,,,AC50,uM,UO_0000065,,10.0
45194,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25120929,[],CHEMBL5291805,Binding affinity towards rat Grin1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL330,Rattus norvegicus,Glutamate (NMDA) receptor subunit zeta 1,10116.0,,,AC50,uM,UO_0000065,,10.0
45195,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25122108,[],CHEMBL5291740,Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method,F,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45196,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25123145,[],CHEMBL5291742,Binding affinity towards human ADRB2 in an in vitro assay with cellular components measured by radioactivity method,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45197,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25124289,[],CHEMBL5291890,Binding affinity towards human SLC6A3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,AC50,uM,UO_0000065,,10.0
45198,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25126423,[],CHEMBL5291770,Binding affinity towards human CHRNA4 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1882,Homo sapiens,Neuronal acetylcholine receptor protein alpha-4 subunit,9606.0,,,AC50,uM,UO_0000065,,10.0
45199,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25127138,[],CHEMBL5291722,"Compound was evaluated for inhibition of human ABCB11 in an in vitro assay with cellular components measured by filtration, liquid scintillation counting",F,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,300000.0,CHEMBL6020,Homo sapiens,Bile salt export pump,9606.0,,,AC50,uM,UO_0000065,,300.0
45200,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25128336,[],CHEMBL5291798,Binding affinity towards rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,10.0
45201,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25129745,[],CHEMBL5291853,"Binding affinity towards human OPRK1 in an in vitro assay with cellular components measured by membrane filtration, scintillation proximity assay",B,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45202,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25130931,[],CHEMBL5291801,Compound was evaluated for inhibition of rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,10.0
45203,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25132138,[],CHEMBL5291823,Binding affinity towards human HTR2C in an in vitro assay with cellular components measured by radioactivity method,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45204,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25133335,[],CHEMBL5291724,Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45205,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25134547,[],CHEMBL5291727,Binding affinity towards human ADORA3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45206,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25135804,[],CHEMBL5291763,Compound was evaluated for inhibition of human CHRM1 in an in vitro assay with cellular components measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,30.0
45207,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25137020,[],CHEMBL5291767,Binding affinity towards human CHRM3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,AC50,uM,UO_0000065,,30.0
45208,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25138122,[],CHEMBL5291732,Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45209,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25140682,[],CHEMBL5291781,"Binding affinity towards human DRD2 in an in vitro assay with cellular components measured by membrane filtration, scintillation proximity assay",B,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45210,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25141856,[],CHEMBL5291880,Binding affinity towards human SLC29A1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1997,Homo sapiens,Equilibrative nucleoside transporter 1,9606.0,,,AC50,uM,UO_0000065,,10.0
45211,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25144039,[],CHEMBL5291737,Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45212,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25145335,[],CHEMBL5291891,Binding affinity towards human SLC6A2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,AC50,uM,UO_0000065,,10.0
45213,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25147127,[],CHEMBL5291854,Agonist activity at human OPRM1 in an in vitro assay with cellular components measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45214,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25148225,[],CHEMBL5291738,Compound was evaluated for inhibition of human ADRA2C in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45215,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25149462,[],CHEMBL5291824,"Compound was evaluated for inhibition of human HTR3A in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1899,Homo sapiens,Serotonin 3a (5-HT3a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45216,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25150667,[],CHEMBL5291892,Binding affinity towards human SLC6A4 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,AC50,uM,UO_0000065,,10.0
45217,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25152812,[],CHEMBL5291726,Binding affinity towards human ADORA2A in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45218,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25154408,[],CHEMBL5291852,Binding affinity towards human OPRD1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45219,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25155498,[],CHEMBL5291889,Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45220,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25157657,[],CHEMBL5291894,Binding affinity towards human OPRM1 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45221,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25160019,[],CHEMBL5291895,Compound was evaluated for inhibition of human MAOA in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,AC50,uM,UO_0000065,,30.0
45222,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25162445,[],CHEMBL5291750,Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1889,Homo sapiens,Vasopressin V1a receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45223,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25163574,[],CHEMBL5291751,Binding affinity towards human AVPR2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1790,Homo sapiens,Vasopressin V2 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45224,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25166516,[],CHEMBL5291870,Compound was evaluated for inhibition of human PTGS2 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,AC50,uM,UO_0000065,,10.0
45225,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25167604,[],CHEMBL5291791,Binding affinity towards human ESR1 in an in vitro cell free assay (NIBR assay) measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,AC50,uM,UO_0000065,,10.0
45226,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25169656,[],CHEMBL5291810,Agonist activity at human HRH2 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45227,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25170765,[],CHEMBL5291753,Binding affinity towards human BDKRB2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45228,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25173083,[],CHEMBL5291803,Binding affinity towards human GHSR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL4616,Homo sapiens,Ghrelin receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45229,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25174728,[],CHEMBL5291868,Compound was evaluated for inhibition of rat Ptgs1 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL4042,Rattus norvegicus,Cyclooxygenase-1,10116.0,,,AC50,uM,UO_0000065,,10.0
45230,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25176157,[],CHEMBL5291850,"Binding affinity towards human NR3C1 in an in vitro cell free assay measured by filtration, radioactivity method",B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45231,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25177320,[],CHEMBL5291744,Binding affinity towards human AGTR1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL227,Homo sapiens,Type-1 angiotensin II receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45232,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25178534,[],CHEMBL5291757,Binding affinity towards human CCKAR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45233,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25180854,[],CHEMBL5291777,Agonist activity at human DRD1 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45234,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25181816,[],CHEMBL5291773,Binding affinity towards human CNR1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45235,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25183735,[],CHEMBL5291831,Binding affinity towards human MC3R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,AC50,uM,UO_0000065,,10.0
45236,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25184604,[],CHEMBL5291832,Binding affinity towards human MC4R in an in vitro assay with cellular components measured by scintillation proximity assay in vitro assay with cellular components,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,AC50,uM,UO_0000065,,10.0
45237,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25185675,[],CHEMBL5291858,Compound was evaluated for inhibition of human PDE4D in an in vitro cell free assay measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL288,Homo sapiens,Phosphodiesterase 4D,9606.0,,,AC50,uM,UO_0000065,,30.0
45238,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25186831,[],CHEMBL5291834,Binding affinity towards human NPY1R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,AC50,uM,UO_0000065,,10.0
45239,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25187637,[],CHEMBL5291748,Binding affinity towards rat Ar in an in vitro cell free assay measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,AC50,uM,UO_0000065,,10.0
45240,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25188416,[],CHEMBL5291846,Binding affinity towards human NR1I2 in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL3401,Homo sapiens,Pregnane X receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45241,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25189512,[],CHEMBL5291833,Binding affinity towards human MLNR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2203,Homo sapiens,Motilin receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45242,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25191041,[],CHEMBL5291898,Compound was evaluated for inhibition of human PDE3A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL241,Homo sapiens,Phosphodiesterase 3A,9606.0,,,AC50,uM,UO_0000065,,30.0
45243,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25193868,[],CHEMBL5291899,Binding affinity towards human DRD3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45244,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25212859,[],CHEMBL5291809,Binding affinity towards human HRH1 in an in vitro assay measured by filtration,B,,,BAO_0000186,BAO_0000357,single protein format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45245,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25214060,[],CHEMBL5291765,Antagonist activity at human CHRM2 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,10.0
45246,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25215268,[],CHEMBL5291764,Agonist activity at human CHRM2 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,10.0
45247,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25216253,[],CHEMBL5291814,Antagonist activity at human HTR1A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45248,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25217347,[],CHEMBL5291813,Agonist activity at human HTR1A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45249,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25218321,[],CHEMBL5291901,Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45250,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25220220,[],CHEMBL5291735,Antagonist activity at human ADRA2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45251,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25221419,[],CHEMBL5291734,Agonist activity at human ADRA2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45252,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25222374,[],CHEMBL5291861,Antagonist activity at human PGR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45253,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25223295,[],CHEMBL5291860,Agonist activity at human PGR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45254,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25225481,[],CHEMBL5291817,Antagonist activity at human HTR2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45255,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25226659,[],CHEMBL5291816,Agonist activity at human HTR2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45256,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25227849,[],CHEMBL5291821,Antagonist activity at human HTR2B in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45257,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25229045,[],CHEMBL5291819,Agonist activity at human HTR2B in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
45258,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25230081,[],CHEMBL5291729,Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,http://www.openphacts.org/units/Nanomolar,3940540,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45259,,,91643,[],CHEMBL638024,Cellular permeability (Pc) (Caco-2 cell monolayer),A,,,BAO_0000179,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1134498,J Med Chem,2001.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,99717,=,1,0,=,,Pc,cm s-1,,270000.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Pc,cm s-1,,,270000.0
45260,,,91644,[],CHEMBL635760,Apparent permeability coefficient (Papp) (Caco-2 cell monolayer),A,,,BAO_0002808,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1134498,J Med Chem,2001.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,99717,=,1,0,=,,Papp,cm s-1,,300000.0,CHEMBL612558,,ADMET,,,,Papp,cm s-1,,,300000.0
45261,,,91645,[],CHEMBL851239,Ratio of [(apical to basal)/(basal to apical)] (Caco-2 cell monolayer),A,,,BAO_0000193,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1134498,J Med Chem,2001.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,99717,=,1,0,=,,Ratio,,,1.4,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Ratio,,,,1.4
45262,,,91646,[],CHEMBL637072,Fraction absorbed after oral administration in humans,A,,,BAO_0000179,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1134498,J Med Chem,2001.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,99717,=,1,0,=,,FA,,,0.6,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,FA,,,,0.6
45263,,,321749,[],CHEMBL634557,Percent of drug absorbed by human intestine after oral administration,A,,,BAO_0000179,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1133113,J Med Chem,2000.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,233452,=,1,0,=,,FA,%,,0.6,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,FA,%,UO_0000187,,0.6
45264,,,392763,[],CHEMBL676875,Inhibitory concentration against Escherichia coli heat-labile enterotoxin (LT) binding to ganglioside GD1b was determined by ELISA assay,B,,,BAO_0000190,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1132211,J Med Chem,1999.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,4.82,0,http://www.openphacts.org/units/Nanomolar,85025,=,1,1,=,,IC50,nM,,15000.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,15.0
45265,,,676576,[],CHEMBL637073,Estimation of fraction absorbed (Fa) in the human intestine using biosensor technology.,A,,,BAO_0000179,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1133190,J Med Chem,2000.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,113013,=,1,0,=,,Fa,%,,0.6,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Fa,%,UO_0000187,,0.6
45266,,,676577,[],CHEMBL761129,Binding to POPC/GMI liposomes using biosensor system,F,,,BAO_0000179,BAO_0000251,microsome format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1133190,J Med Chem,2000.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,113013,=,1,0,=,,Other,,,29.0,CHEMBL614676,,Liposome,,,,Other,,,,29.0
45267,,,676578,[],CHEMBL761127,Binding to POPC (palmitoyl-oleolyl-phosphatidyl-choline) liposomes using biosensor system,F,,,BAO_0000179,BAO_0000251,microsome format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1133190,J Med Chem,2000.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,113013,=,1,0,=,,Other,,,22.0,CHEMBL614676,,Liposome,,,,Other,,,,22.0
45268,,,923367,[],CHEMBL623449,Percent recovery of 10 ug/mL compound after administration in cirrhotic patients,A,,,BAO_0000179,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,136494,=,1,0,=,,Recovery,%,,93.1,CHEMBL612558,,ADMET,,,,Recovery,%,UO_0000187,,93.1
45269,,,923368,[],CHEMBL623448,Percent recovery of 100 ug/mL compound after administration in cirrhotic patients,A,,,BAO_0000179,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,136494,=,1,0,=,,Recovery,%,,93.7,CHEMBL612558,,ADMET,,,,Recovery,%,UO_0000187,,93.7
45270,,,923369,[],CHEMBL623450,Percent recovery of 500 ug/mL compound after administration in cirrhotic patients,A,,,BAO_0000179,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,136494,=,1,0,=,,Recovery,%,,97.0,CHEMBL612558,,ADMET,,,,Recovery,%,UO_0000187,,97.0
45271,,,923370,[],CHEMBL618250,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection (Group A and B),A,,,BAO_0001103,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,136494,=,1,0,=,,Activity,%,,0.00719,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,0.00719
45272,,,923371,[],CHEMBL618254,Percent of compound in cirrhotic patients of sterile ascitic fluid (Group C),A,,,BAO_0001103,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,136494,=,1,0,=,,Activity,%,,0.00476,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,0.00476
45273,,,923372,[],CHEMBL618255,Percent of compound in healthy individuals (Group D),A,,,BAO_0001103,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,136494,=,1,0,=,,Activity,%,,0.00177,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,0.00177
45274,,,923373,[],CHEMBL846328,Ratio of lactulose and mannitol in cirrhotic patients of spontaneous ascitic fluid infection (Group A and B),A,,,BAO_0000193,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,136494,=,1,0,=,,Ratio,,,0.1003,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Ratio,,,,0.1003
45275,,,923374,[],CHEMBL846329,Ratio of lactulose and mannitol in cirrhotic patients of sterile ascitic fluid (Group C),A,,,BAO_0000193,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,136494,=,1,0,=,,Ratio,,,0.0715,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Ratio,,,,0.0715
45276,,,923375,[],CHEMBL846330,Ratio of lactulose and mannitol in healthy individuals (Group D),A,,,BAO_0000193,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,136494,=,1,0,=,,Ratio,,,0.0209,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Ratio,,,,0.0209
45277,,,923376,[],CHEMBL618252,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection before dosing with normal antibiotics,A,,,BAO_0001103,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,136494,=,1,0,=,,Activity,%,,0.007,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,0.007
45278,,,923377,[],CHEMBL874598,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection after dosing with normal antibiotics,A,,,BAO_0001103,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,136494,=,1,0,=,,Activity,%,,0.006,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,0.006
45279,,,923378,[],CHEMBL847199,Ratio of percent compound before and after dosing in cirrhotic patients of spontaneous ascitic fluid infection,A,,,BAO_0000193,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,136494,=,1,0,=,,Ratio,,,0.1009,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Ratio,,,,0.1009
45280,,,923379,[],CHEMBL847198,Ratio of percent compound after dosing in cirrhotic patients of spontaneous ascitic fluid infection,A,,,BAO_0000193,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,136494,=,1,0,=,,Ratio,,,0.0814,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Ratio,,,,0.0814
45281,,,923380,[],CHEMBL618253,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection before dosing with normal antibiotics and lactose,A,,,BAO_0001103,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,136494,=,1,0,=,,Activity,%,,0.0071,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,0.0071
45282,,,923381,[],CHEMBL618251,Percent of compound in cirrhotic patients of spontaneous ascitic fluid infection after dosing with normal antibiotics and lactose,A,,,BAO_0001103,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,136494,=,1,0,=,,Activity,%,,0.0044,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,0.0044
45283,,,923382,[],CHEMBL847200,Ratio of percent compound before dosing in cirrhotic patients of spontaneous ascitic fluid infection,A,,,BAO_0000193,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,136494,=,1,0,=,,Ratio,,,0.1009,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Ratio,,,,0.1009
45284,,,923383,[],CHEMBL847198,Ratio of percent compound after dosing in cirrhotic patients of spontaneous ascitic fluid infection,A,,,BAO_0000193,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1148239,Bioorg Med Chem Lett,2004.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,136494,=,1,0,=,,Ratio,,,0.0572,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Ratio,,,,0.0572
45285,,,1011226,[],CHEMBL630253,Percent of the drug absorbed after administration to humans was determined,A,,,BAO_0000179,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1132208,J Med Chem,1999.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,81395,=,1,0,=,,Absorption,%,,0.6,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Absorption,%,UO_0000187,,0.6
45286,,,1406544,[],CHEMBL851908,Permeability Coefficient in Caco-2 cell culture model,A,,,BAO_0002808,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1145178,J Med Chem,2005.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,361453,=,1,0,=,,Papp,cm/s * 10E6,,0.27,CHEMBL612558,,ADMET,,,,Papp,cm/s * 10E6,,,0.27
45287,,,1406545,[],CHEMBL851907,Permeability Coefficient in 2/4/A1 cell model,A,,,BAO_0002808,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1145178,J Med Chem,2005.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,361453,=,1,0,=,,Papp,cm/s * 10E6,,8.9,CHEMBL612558,,ADMET,,,,Papp,cm/s * 10E6,,,8.9
45288,,,1406546,[],CHEMBL851909,Permeability Coefficient in hexadecane membranes model,A,,,BAO_0002808,BAO_0000249,cell membrane format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1145178,J Med Chem,2005.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,361453,=,1,0,=,,Papp,cm/s * 10E6,,0.081,CHEMBL612558,,ADMET,,,,Papp,cm/s * 10E6,,,0.081
45289,,,1406547,[],CHEMBL826140,Percentage of mass balance in hexadecane membranes model,A,,,BAO_0002808,BAO_0000249,cell membrane format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1145178,J Med Chem,2005.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,361453,=,1,0,=,,Papp,cm/s * 10E6,,98.0,CHEMBL612558,,ADMET,,,,Papp,cm/s * 10E6,,,98.0
45290,,,1406548,[],CHEMBL840340,Fraction absorbed in human intestine after oral administration compound was measured,A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1145178,J Med Chem,2005.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,361453,=,1,0,=,,FA,%,,1.0,CHEMBL612558,,ADMET,,,,FA,%,UO_0000187,,1.0
45291,,,1504556,[],CHEMBL828190,Tested for fraction of oral dose absorbed orally in humans,A,,,BAO_0001103,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1143634,J Med Chem,2005.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,390410,=,1,0,=,,Activity,%,,0.6,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,0.6
45292,,,2502653,[],CHEMBL988687,Inhibition of Trypanosoma cruzi trans-Sialidase,B,,,BAO_0000190,BAO_0000357,single protein format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1143384,Bioorg Med Chem Lett,2009.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,780272,=,1,1,=,,IC50,nM,,570000.0,CHEMBL5126,Trypanosoma cruzi,Trans-sialidase,5693.0,,,IC50,mM,UO_0000065,,0.57
45293,,,3264702,[],CHEMBL1116254,Human intestinal absorption in po dosed human,A,,,BAO_0001103,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1157012,Eur J Med Chem,2010.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,905992,=,1,0,=,,Activity,%,,0.01,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,0.01
45294,,Inconclusive,3629624,[],CHEMBL1614531,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1201862,,,,CHEMBL296306,LACTULOSE,CHEMBL296306,4.4,0,http://www.openphacts.org/units/Nanomolar,1161459,=,7,1,=,,Potency,nM,,39810.7,CHEMBL2093861,Homo sapiens,Menin/Histone-lysine N-methyltransferase MLL,9606.0,,,Potency,um,UO_0000065,,39.8107
45295,,,5170244,[],CHEMBL1663502,Drug absorption in human assessed as human intestinal absorption rate,A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1649380,Eur J Med Chem,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1325408,=,1,0,=,,log10(%HIA +10),,,1.025,CHEMBL612558,,ADMET,,,,log10(%HIA +10),,,,1.025
45296,,drug-induced liver injury reported,5317511,[],CHEMBL1697778,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1341297,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
45297,,drug-induced liver injury reported,5318462,[],CHEMBL1697779,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1341297,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
45298,,no drug-induced liver injury reported,5319413,[],CHEMBL1697780,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1341297,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
45299,,,6173656,[],CHEMBL1769835,Apparent permeability across human Caco2 cell membrane after 2 hrs by LC-MS/MS analysis,A,,,BAO_0000179,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1764994,Bioorg Med Chem,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1415523,=,1,0,=,,logPapp,,,-6.52,CHEMBL614058,Homo sapiens,Caco-2,9606.0,,,logPapp,,,,-6.52
45300,,inconclusive,7031533,[],CHEMBL1794499,PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856],F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1201862,,,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,1161459,,7,1,,,Potency,nM,,2119.2,CHEMBL1795091,Homo sapiens,Regulator of G-protein signaling 4,9606.0,,,Potency,uM,UO_0000065,,2.1192
45301,,DILI severity category; not applicable,7829153,[],CHEMBL1909293,FDA Liver Toxicity Knowledge Base Benchmark Dataset (LTKB-BD) drugs of no concern for DILI,T,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1909281,Drug Discov Today,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1540440,,1,0,,,LTKB_BD DILI severity score,,,,CHEMBL1697861,,Hepatotoxicity,,,,LTKB_BD DILI severity score,,,,
45302,,,7831001,[],CHEMBL1909307,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1540909,=,1,0,=,,HepSE_bilirubinemia,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_bilirubinemia,,,,0.0
45303,,,7831002,[],CHEMBL1909308,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1540909,=,1,0,=,,HepSE_cholecystitis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholecystitis,,,,0.0
45304,,,7831003,[],CHEMBL1909309,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1540909,=,1,0,=,,HepSE_cholelithiasis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholelithiasis,,,,0.0
45305,,,7831004,[],CHEMBL1909310,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1540909,=,1,0,=,,HepSE_cirrhosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cirrhosis,,,,0.0
45306,,,7831005,[],CHEMBL1909311,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1540909,=,1,0,=,,HepSE_elevated liver function tests,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_elevated liver function tests,,,,0.0
45307,,,7831006,[],CHEMBL1909312,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1540909,=,1,0,=,,HepSE_hepatic failure,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic failure,,,,0.0
45308,,,7831007,[],CHEMBL1909313,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1540909,=,1,0,=,,HepSE_hepatic necrosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic necrosis,,,,0.0
45309,,,7831008,[],CHEMBL1909314,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1540909,=,1,0,=,,HepSE_hepatitis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatitis,,,,0.0
45310,,,7831009,[],CHEMBL1909315,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1540909,=,1,0,=,,HepSE_hepatomegaly,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatomegaly,,,,0.0
45311,,,7831010,[],CHEMBL1909316,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1540909,=,1,0,=,,HepSE_jaundice,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_jaundice,,,,0.0
45312,,,7831011,[],CHEMBL1909317,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1540909,=,1,0,=,,HepSE_liver disease,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver disease,,,,0.0
45313,,,7831012,[],CHEMBL1909318,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1540909,=,1,0,=,,HepSE_liver fatty,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver fatty,,,,0.0
45314,,,7831013,[],CHEMBL1909319,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1540909,=,1,0,=,,HepSE_liver function tests abnormal,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver function tests abnormal,,,,0.0
45315,,,7831014,[],CHEMBL1909320,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,A,,,BAO_0000179,BAO_0000221,tissue-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,1540909,=,1,0,=,,HepSE_Combined Scores,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_Combined Scores,,,,0.0
45316,,,13798308,[],CHEMBL3039491,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,A,,,BAO_0000201,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL3039007,Mol Pharmacol,2013.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,1937663,=,1,1,=,,Inhibition,%,,104.92,CHEMBL1743121,Homo sapiens,Solute carrier organic anion transporter family member 1B3,9606.0,,,Inhibition,%,UO_0000187,,104.9237315
45317,,,13800306,[],CHEMBL3039488,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,A,,,BAO_0000201,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL3039007,Mol Pharmacol,2013.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,1937663,=,1,1,=,,Inhibition,%,,90.31,CHEMBL1697668,Homo sapiens,Solute carrier organic anion transporter family member 1B1,9606.0,,,Inhibition,%,UO_0000187,,90.30949291
45318,,inactive,15494680,[],CHEMBL3562119,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1201862,,,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,2047854,,7,1,,,AC50,nM,,15848.9,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,15.8489
45319,,inactive,15539952,[],CHEMBL3562064,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1201862,,,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Micromolar,2047854,,7,0,,,Ac50,uM,,0.7943,CHEMBL612545,,Unchecked,,,,Ac50,uM,UO_0000064,,0.794328235
45320,,inactive,15567793,[],CHEMBL3561990,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1201862,,,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Micromolar,2047854,,7,0,,,Ac50,uM,,15.85,CHEMBL612545,,Unchecked,,,,Ac50,uM,UO_0000064,,15.84893192
45321,,inactive,15593024,[],CHEMBL3562152,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1201862,,,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Micromolar,2047854,,7,0,,,Ac50,uM,,1.585,CHEMBL612545,,Unchecked,,,,Ac50,uM,UO_0000064,,1.584893193
45322,,inactive,15596446,[],CHEMBL3562136,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1201862,,,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,2047854,,7,1,,,AC50,nM,,794.3,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,0.7943
45323,,inactive,15597238,[],CHEMBL3562146,"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel.   (Class of assay: confirmatory) ",F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL1201862,,,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,2047854,,7,1,,,AC50,nM,,1584.9,CHEMBL612545,,Unchecked,,,,AC50,uM,UO_0000065,,1.5849
45324,,,18132503,[],CHEMBL4029349,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index,T,,,BAO_0000179,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,3007501,=,1,0,=,,DILI_severity_class,,,0.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_severity_class,,,,0.0
45325,,No-Dili-Concern,18133103,[],CHEMBL4029350,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status,T,,,BAO_0000179,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,3007501,,1,0,,,DILI_Concern,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_Concern,,,,
45326,,,18715248,[],CHEMBL4257125,Oral bioavailability in human,A,,,BAO_0003042,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL4257082,,2016.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3108729,=,38,1,=,,F,%,,0.6,CHEMBL612558,,ADMET,,,,F,%,UO_0000187,,0.6
45327,,,18829939,[],CHEMBL4303805,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL4303101,,2020.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3136437,=,52,1,=,,Inhibition,%,,12.66,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Inhibition,%,UO_0000187,,12.66
45328,,,18836317,[],CHEMBL4303810,Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits),F,,,BAO_0000179,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL4303122,,2020.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,,3142587,=,52,0,=,,Hit score,,,0.1124,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Hit score,,,,0.112425631
45329,,,19963171,[],CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate,F,,,BAO_0000201,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL4495564,,2020.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3349589,=,52,1,=,,Inhibition,%,,32.94,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,,Inhibition,%,UO_0000187,,32.94047002
45330,,,20150060,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL4495565,,2020.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3367461,=,52,1,=,,Inhibition,%,,-0.17,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.17
45331,,,22078951,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL4495565,,2020.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3367461,=,52,1,=,,Inhibition,%,,-0.17,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.17
45332,,No. Measurements = 1,22081226,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL4651402,,2021.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3491299,>,57,1,>,,IC50,nM,,20000.0,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,IC50,M,UO_0000065,,2e-05
45333,,No. Measurements = 1,22081227,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL4651402,,2021.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3491299,<,57,1,>,,IC50,nM,,19952.62,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,pIC50,,UO_0000065,,4.7
45334,,,23132489,[],CHEMBL4808149,Enzymatic assay of human HDAC6 with commercial peptide substrate,B,,,BAO_0000201,BAO_0000357,single protein format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL4808148,,2021.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3595742,=,59,1,=,,Inhibition,%,,2.0,CHEMBL1865,Homo sapiens,Histone deacetylase 6,9606.0,,,inhibition,%,UO_0000187,,2.0
45335,,,23137743,[],CHEMBL4808150,Enzymatic assay of human HDAC6 with custom peptide substrate,B,,,BAO_0000201,BAO_0000357,single protein format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL4808148,,2021.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3595742,=,59,1,=,,Inhibition,%,,-1.09,CHEMBL1865,Homo sapiens,Histone deacetylase 6,9606.0,,,inhibition,%,UO_0000187,,-1.09
45336,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,24690964,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '20.0'}]",CHEMBL5105693,Binding affinity to human telomeric IKF1 G4 quadruplex DNA assessed as change in melting temperature at 20 uM at pH 7.4 by FRET assay,B,,,BAO_0000179,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#DegreeCelsius,3849828,=,1,1,=,,Delta Tm,degrees C,,-4.0,CHEMBL3832742,Homo sapiens,quadruplex DNA,9606.0,,,deltaTm,degrees C,UO_0000027,,-4.0
45337,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,24690971,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '20.0'}]",CHEMBL5105694,Binding affinity to human telomeric 1ELN i-motif DNA assessed as change in melting temperature at 20 uM at pH 7.4 by FRET assay,B,,,BAO_0000179,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#DegreeCelsius,3849828,=,1,1,=,,Delta Tm,degrees C,,-3.7,CHEMBL4845622,,i-motif DNA,,,,deltaTm,degrees C,UO_0000027,,-3.7
45338,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,24690978,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '20.0'}]",CHEMBL5105695,Binding affinity to human telomeric 1ELN i-motif DNA assessed as change in melting temperature at 20 uM at pH 5.5 by FRET assay,B,,,BAO_0000179,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#DegreeCelsius,3849828,=,1,1,=,,Delta Tm,degrees C,,-0.4,CHEMBL4845622,,i-motif DNA,,,,deltaTm,degrees C,UO_0000027,,-0.4
45339,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,24690985,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '20.0'}]",CHEMBL5105696,Binding affinity to human ILPR G4 quadruplex DNA assessed as change in melting temperature at 20 uM at pH 7.4 by FRET assay,B,,,BAO_0000179,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#DegreeCelsius,3849828,=,1,1,=,,Delta Tm,degrees C,,-4.6,CHEMBL3832742,Homo sapiens,quadruplex DNA,9606.0,,,deltaTm,degrees C,UO_0000027,,-4.6
45340,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,24690992,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '20.0'}]",CHEMBL5105697,Binding affinity to human ILPR i-motif DNA assessed as change in melting temperature at 20 uM at pH 7.4 by FRET assay,B,,,BAO_0000179,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#DegreeCelsius,3849828,=,1,1,=,,Delta Tm,degrees C,,-2.7,CHEMBL4845622,,i-motif DNA,,,,deltaTm,degrees C,UO_0000027,,-2.7
45341,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,24690999,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '20.0'}]",CHEMBL5105698,Binding affinity to human ILPR i-motif DNA assessed as change in melting temperature at 20 uM at pH 5.5 by FRET assay,B,,,BAO_0000179,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#DegreeCelsius,3849828,=,1,1,=,,Delta Tm,degrees C,,-0.3,CHEMBL4845622,,i-motif DNA,,,,deltaTm,degrees C,UO_0000027,,-0.3
45342,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,24691006,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '20.0'}]",CHEMBL5105699,Binding affinity to human 1BNA double stranded DNA assessed as change in melting temperature at 20 uM at pH 7.4 by FRET assay,B,,,BAO_0000179,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#DegreeCelsius,3849828,=,1,1,=,,Delta Tm,degrees C,,-2.7,CHEMBL3832741,Homo sapiens,dsDNA,9606.0,,,deltaTm,degrees C,UO_0000027,,-2.7
45343,,,24691013,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'equiv', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'equiv', 'value': '10.0'}]",CHEMBL5105700,Displacement of thiazole orange from human telomeric IKF1 G4 quadruplex DNA at 10 equiv. at pH 7.4 by fluorescent intercalator displacement assay,B,,,BAO_0001103,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3849828,=,1,0,=,,Activity,%,,21.4,CHEMBL3832742,Homo sapiens,quadruplex DNA,9606.0,,,Activity,%,UO_0000187,,21.4
45344,,,24691020,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'equiv', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'equiv', 'value': '100.0'}]",CHEMBL5105701,Displacement of thiazole orange from human telomeric IKF1 G4 quadruplex DNA at 100 equiv. at pH 7.4 by fluorescent intercalator displacement assay,B,,,BAO_0001103,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3849828,=,1,0,=,,Activity,%,,26.1,CHEMBL3832742,Homo sapiens,quadruplex DNA,9606.0,,,Activity,%,UO_0000187,,26.1
45345,,,24691027,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'equiv', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'equiv', 'value': '10.0'}]",CHEMBL5105702,Displacement of thiazole orange from human telomeric 1ELN i-motif DNA at 10 equiv. at pH 7.4 by fluorescent intercalator displacement assay,B,,,BAO_0001103,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3849828,=,1,0,=,,Activity,%,,-54.0,CHEMBL4845622,,i-motif DNA,,,,Activity,%,UO_0000187,,-54.0
45346,,,24691034,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'equiv', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'equiv', 'value': '100.0'}]",CHEMBL5105703,Displacement of thiazole orange from human telomeric 1ELN i-motif DNA at 100 equiv. at pH 7.4 by fluorescent intercalator displacement assay,B,,,BAO_0001103,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3849828,=,1,0,=,,Activity,%,,-68.0,CHEMBL4845622,,i-motif DNA,,,,Activity,%,UO_0000187,,-68.0
45347,,,24691041,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'equiv', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'equiv', 'value': '10.0'}]",CHEMBL5105704,Displacement of thiazole orange from human telomeric 1ELN i-motif DNA at 10 equiv. at pH 5.5 by fluorescent intercalator displacement assay,B,,,BAO_0001103,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3849828,=,1,0,=,,Activity,%,,-28.4,CHEMBL4845622,,i-motif DNA,,,,Activity,%,UO_0000187,,-28.4
45348,,,24691048,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'equiv', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'equiv', 'value': '100.0'}]",CHEMBL5105705,Displacement of thiazole orange from human telomeric 1ELN i-motif DNA at 100 equiv. at pH 5.5 by fluorescent intercalator displacement assay,B,,,BAO_0001103,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3849828,=,1,0,=,,Activity,%,,20.2,CHEMBL4845622,,i-motif DNA,,,,Activity,%,UO_0000187,,20.2
45349,,,24691055,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'equiv', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'equiv', 'value': '10.0'}]",CHEMBL5105706,Displacement of thiazole orange from human ILPR G4 quadruplex DNA at 10 equiv. at pH 7.4 by fluorescent intercalator displacement assay,B,,,BAO_0001103,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3849828,=,1,0,=,,Activity,%,,0.9,CHEMBL3832742,Homo sapiens,quadruplex DNA,9606.0,,,Activity,%,UO_0000187,,0.9
45350,,,24691062,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'equiv', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'equiv', 'value': '100.0'}]",CHEMBL5105707,Displacement of thiazole orange from human ILPR G4 quadruplex DNA at 100 equiv. at pH 7.4 by fluorescent intercalator displacement assay,B,,,BAO_0001103,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3849828,=,1,0,=,,Activity,%,,0.4,CHEMBL3832742,Homo sapiens,quadruplex DNA,9606.0,,,Activity,%,UO_0000187,,0.4
45351,,,24691069,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'equiv', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'equiv', 'value': '10.0'}]",CHEMBL5105708,Displacement of thiazole orange from human ILPR i-motif DNA at 10 equiv. at pH 7.4 by fluorescent intercalator displacement assay,B,,,BAO_0001103,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3849828,=,1,0,=,,Activity,%,,26.7,CHEMBL4845622,,i-motif DNA,,,,Activity,%,UO_0000187,,26.7
45352,,,24691076,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'equiv', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'equiv', 'value': '100.0'}]",CHEMBL5105709,Displacement of thiazole orange from human ILPR i-motif DNA at 100 equiv. at pH 7.4 by fluorescent intercalator displacement assay,B,,,BAO_0001103,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3849828,=,1,0,=,,Activity,%,,34.7,CHEMBL4845622,,i-motif DNA,,,,Activity,%,UO_0000187,,34.7
45353,,,24691083,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'equiv', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'equiv', 'value': '10.0'}]",CHEMBL5105710,Displacement of thiazole orange from human ILPR i-motif DNA at 10 equiv. at pH 5.5 by fluorescent intercalator displacement assay,B,,,BAO_0001103,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3849828,=,1,0,=,,Activity,%,,-5.0,CHEMBL4845622,,i-motif DNA,,,,Activity,%,UO_0000187,,-5.0
45354,,,24691090,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'equiv', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'equiv', 'value': '100.0'}]",CHEMBL5105711,Displacement of thiazole orange from human ILPR i-motif DNA at 100 equiv. at pH 5.5 by fluorescent intercalator displacement assay,B,,,BAO_0001103,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3849828,=,1,0,=,,Activity,%,,23.1,CHEMBL4845622,,i-motif DNA,,,,Activity,%,UO_0000187,,23.1
45355,,,24691097,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'equiv', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'equiv', 'value': '10.0'}]",CHEMBL5105712,Displacement of thiazole orange from human 1BNA double stranded DNA at 10 equiv. at pH 7.4 by fluorescent intercalator displacement assay,B,,,BAO_0001103,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3849828,=,1,0,=,,Activity,%,,4.3,CHEMBL3832741,Homo sapiens,dsDNA,9606.0,,,Activity,%,UO_0000187,,4.3
45356,,,24691104,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'equiv', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'equiv', 'value': '100.0'}]",CHEMBL5105713,Displacement of thiazole orange from human 1BNA double stranded DNA at 100 equiv. at pH 7.4 by fluorescent intercalator displacement assay,B,,,BAO_0001103,BAO_0000225,nucleic acid format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5104132,Bioorg Med Chem Lett,2022.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://qudt.org/vocab/unit#Percent,3849828,=,1,0,=,,Activity,%,,9.0,CHEMBL3832741,Homo sapiens,dsDNA,9606.0,,,Activity,%,UO_0000187,,9.0
45357,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25115596,[],CHEMBL5291779,Binding affinity towards human DRD1 in an in vitro assay with cellular components (NIBR assay) measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45358,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25118391,[],CHEMBL5291828,"Compound was evaluated for inhibition of human KCNH2 in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,10000.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,AC50,uM,UO_0000065,,10.0
45359,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25125345,[],CHEMBL5291882,Binding affinity towards human SLC6A3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
45360,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25127154,[],CHEMBL5291722,"Compound was evaluated for inhibition of human ABCB11 in an in vitro assay with cellular components measured by filtration, liquid scintillation counting",F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,300000.0,CHEMBL6020,Homo sapiens,Bile salt export pump,9606.0,,,AC50,uM,UO_0000065,,300.0
45361,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25139244,[],CHEMBL5291792,Binding affinity towards human ESR1 in an in vitro cell free assay (CRO assay) measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,AC50,uM,UO_0000065,,30.0
45362,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25142934,[],CHEMBL5291723,Compound was evaluated for inhibition of human ACHE in an vitro cell free assay measured by absorbance method,F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,AC50,uM,UO_0000065,,30.0
45363,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25146386,[],CHEMBL5291881,Binding affinity towards human SLC6A2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
45364,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25151713,[],CHEMBL5291883,Binding affinity towards human SLC6A4 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
45365,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25156815,[],CHEMBL5291736,Binding affinity towards human ADRA2A in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45366,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25158561,[],CHEMBL5291855,Binding affinity towards human OPRM1 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45367,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25161077,[],CHEMBL5291830,Compound was evaluated for inhibition of human MAOA in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,AC50,uM,UO_0000065,,30.0
45368,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25165410,[],CHEMBL5291815,Binding affinity towards human HTR1A in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45369,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25168508,[],CHEMBL5291829,Compound was evaluated for inhibition of human KDR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL279,Homo sapiens,Vascular endothelial growth factor receptor 2,9606.0,,,AC50,uM,UO_0000065,,30.0
45370,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25192103,[],CHEMBL5291856,Compound was evaluated for inhibition of human PDE3A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL241,Homo sapiens,Phosphodiesterase 3A,9606.0,,,AC50,uM,UO_0000065,,30.0
45371,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25194898,[],CHEMBL5291782,Binding affinity towards human DRD3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45372,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25196122,[],CHEMBL5291766,Binding affinity towards human CHRM2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,30.0
45373,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25197092,[],CHEMBL5291794,Compound was evaluated for inhibition of human F2 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL204,Homo sapiens,Thrombin,9606.0,,,AC50,uM,UO_0000065,,30.0
45374,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25198231,[],CHEMBL5291888,Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45375,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25199020,[],CHEMBL5291728,Binding affinity towards human ADORA3 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45376,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25199918,[],CHEMBL5291812,Binding affinity towards human HRH3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL264,Homo sapiens,Histamine H3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45377,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25201851,[],CHEMBL5291820,Agonist activity at human HTR2B in an in vitro cell-based assay (CRO assay) measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45378,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25202938,[],CHEMBL5291799,Binding affinity towards human GABRA1 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000223,protein complex format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL5303741,Homo sapiens,Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2,9606.0,,,AC50,uM,UO_0000065,,30.0
45379,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25203744,[],CHEMBL5291749,Binding affinity towards human AR in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1871,Homo sapiens,Androgen Receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45380,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25204677,[],CHEMBL5291863,Binding affinity towards human PGR in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45381,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25205610,[],CHEMBL5291869,Compound was evaluated for inhibition of human PTGS1 in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,AC50,uM,UO_0000065,,30.0
45382,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25206540,[],CHEMBL5291871,Compound was evaluated for inhibition of human PTGS1 in an in vitro cell free assay measured by fluorescence method,F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,AC50,uM,UO_0000065,,30.0
45383,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25207473,[],CHEMBL5291857,Compound was evaluated for inhibition of human PDE4A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL254,Homo sapiens,Phosphodiesterase 4A,9606.0,,,AC50,uM,UO_0000065,,30.0
45384,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25208873,[],CHEMBL5291730,Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45385,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25209719,[],CHEMBL5291759,Agonist activity at human CHRM1 in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,30.0
45386,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25210539,[],CHEMBL5291761,Antagonist activity human CHRM1 in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,30.0
45387,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25211480,[],CHEMBL5291887,Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45388,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25219178,[],CHEMBL5291731,Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL296306,LACTULOSE,CHEMBL296306,,0,http://www.openphacts.org/units/Nanomolar,3940551,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
45389,,,51015,[],CHEMBL679318,Minimum inhibitory concentration against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1132978,J Med Chem,2000.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,16263,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
45390,,,113942,[],CHEMBL711574,In vitro inhibitory activity on MRC5 fibroblast tissue cultures inoculated with virulent RH strain of Toxoplasma gondii,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148256,Bioorg Med Chem Lett,2004.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,4.9,0,http://www.openphacts.org/units/Nanomolar,172943,=,1,1,=,,IC50,nM,,12700.0,CHEMBL614181,Homo sapiens,MRC5,9606.0,,,IC50,uM,UO_0000065,,12.7
45391,,Not Determined,113943,[],CHEMBL764438,In vitro inhibitory activity against hepatic stages of Plasmodium yoelii yoelii 265 BY; No data,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148256,Bioorg Med Chem Lett,2004.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,172943,,1,0,,,IC50,nM,,,CHEMBL612328,Plasmodium yoelii yoelii,Plasmodium yoelii yoelii,73239.0,,,IC50,uM,UO_0000065,,
45392,,,113944,[],CHEMBL760246,In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum NF54-R in blood,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148256,Bioorg Med Chem Lett,2004.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,4.54,0,http://www.openphacts.org/units/Nanomolar,172943,=,1,1,=,,IC50,nM,,29000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,29.0
45393,,,316912,[],CHEMBL812128,Minimum inhibitory concentration against Staphylococcus aureus - methicillin resistant Ciprofloxacin sensitive strain MI300,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145050,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,230788,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
45394,,,316913,[],CHEMBL812127,"Minimum inhibitory concentration against Staphylococcus aureus - methicillin resistant Ciprofloxacin resistant, strain MI339",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145050,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,230788,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
45395,,,316914,[],CHEMBL810065,"Minimum inhibitory concentration against Streptococcus pneumoniae - penicillin sensitive, strain STP64",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145050,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,230788,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
45396,,,316915,[],CHEMBL879557,"Minimum inhibitory concentration against Escherichia coli, strain ES142",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145050,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,230788,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
45397,,,316916,[],CHEMBL765956,"Minimum inhibitory concentration against Pseudomonas aeruginosa, strain PS96",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145050,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,230788,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
45398,,,318313,[],CHEMBL662305,K+ channel blocking activity in Chinese hamster ovary cells expressing HERG Kv11.1,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1135758,J Med Chem,2002.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,240340,=,1,1,=,,IC50,nM,,130000.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,IC50,nM,UO_0000065,,130000.0
45399,,,330614,[],CHEMBL682975,In vitro antibacterial activity was tested for Enterobacter cloacae HA2646,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.05
45400,,,330615,[],CHEMBL682187,In vitro antibacterial activity was tested for Escherichia coli Vogel,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
45401,,,330616,[],CHEMBL682186,In vitro antibacterial activity was tested for Escherichia coli H560,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
45402,,,330617,[],CHEMBL703008,In vitro antibacterial activity was tested for Klebsiella pneumoniae MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
45403,,,330618,[],CHEMBL767624,In vitro antibacterial activity was tested for Providencia rettgeri H1771,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.2
45404,,,330619,[],CHEMBL772736,In vitro antibacterial activity was tested for Pseudomonas aeruginosa UI-18,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.8
45405,,,330620,[],CHEMBL809865,In vitro antibacterial activity was tested for Staphylococcus aureus H228,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
45406,,,330621,[],CHEMBL809866,In vitro antibacterial activity was tested for Staphylococcus aureus UC-76,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
45407,,,330622,[],CHEMBL814002,In vitro antibacterial activity was tested for Streptococcus faecalis MGH-2,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.2
45408,,,330623,[],CHEMBL812243,In vitro antibacterial activity was tested for Streptococcus pneumoniae SV-1,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.1
45409,,,330624,[],CHEMBL813819,In vitro antibacterial activity was tested for Streptococcus pyogenes C203,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.1
45410,,,330625,[],CHEMBL648899,In vitro antibacterial activity against Bacteroides fragilis BFA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,0.4
45411,,,330626,[],CHEMBL656328,In vitro antibacterial activity was tested for Clostridium diff CD1-1,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.6
45412,,,330627,[],CHEMBL659029,In vitro antibacterial activity against Clostridium perfringens CP 3-1,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.4
45413,,,330628,[],CHEMBL858580,In vitro antibacterial activity was tested for Propion acnes PA5-1,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.4
45414,,,330629,[],CHEMBL765433,In vitro antibacterial activity was tested for Pepto asac PA 3-1,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,,MIC,ug ml-1,UO_0000274,,0.8
45415,,,330630,[],CHEMBL811210,Clonogenic cytotoxicity against Chinese hamster V-79 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1128719,J Med Chem,1995.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,269087,=,1,1,=,,IC50,ug.mL-1,,85.0,CHEMBL614074,Cricetulus griseus,V79,10029.0,,,IC50,ug ml-1,UO_0000274,,85.0
45416,,,962827,[],CHEMBL807153,Antibacterial activity was determined against Staphylococcus aureus FDA 209-P strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
45417,,,962828,[],CHEMBL804403,Antibacterial activity was determined against Staphylococcus epidermis 56500 strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.2
45418,,,962829,[],CHEMBL809336,Antibacterial activity was determined against Streptococcus pneumoniae J-24 strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.2
45419,,,962830,[],CHEMBL808948,Antibacterial activity was determined against Streptococcus pyogenes G-36 strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.39
45420,,,962831,[],CHEMBL812014,Antibacterial activity was determined against Streptococcus mitis IID685 strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,0.2
45421,,,962832,[],CHEMBL679636,Antibacterial activity was determined against Enterococcus faecalis ATCC 19433 strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.39
45422,,,962833,[],CHEMBL674794,Antibacterial activity was determined against Escherichia coli NIHJ strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.006
45423,,,962834,[],CHEMBL700140,Antibacterial activity was determined against Klebsiella pneumoniae type II strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.05
45424,,,962835,[],CHEMBL772626,Antibacterial activity was determined against Pseudomonas aeruginosa PAO1 strain after incubation at 37 degrees C for 18 h,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.39
45425,,,962836,[],CHEMBL810350,Antibacterial activity was determined against clinically isolated Levofloxacin-methicillin resistant Staphylococcus aureus (LVFX-r MRSA) strains (74 strains),F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,4.0
45426,,,962837,[],CHEMBL807739,Antibacterial activity was determined against clinically isolated Levofloxacin-methicillin resistant Staphylococcus aureus (LVFX-r MRSA) strains (74 strains),F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,32.0
45427,,,962838,[],CHEMBL814672,Antibacterial activity was determined against clinically isolated penicillin resistant Streptococcus pneumoniae (PRSP) strains (50 strains),F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45428,,,962839,[],CHEMBL817379,Antibacterial activity was determined against clinically isolated penicillin resistant Streptococcus pneumoniae (PRSP) strains (50 strains),F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.25
45429,,,962840,[],CHEMBL673549,Antibacterial activity was determined against clinically isolated vancomycin-A resistant enterococci (VRE) strains (33 strains),F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,,MIC50,ug ml-1,UO_0000274,,16.0
45430,,,962841,[],CHEMBL674199,Antibacterial activity was determined against clinically isolated vancomycin-A resistant enterococci (VRE) strains (33 strains),F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,,MIC90,ug ml-1,UO_0000274,,32.0
45431,,,962842,[],CHEMBL673551,Antibacterial activity was determined against clinically isolated vancomycin-B resistant enterococci (VRE) strains (10 strains),F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,,MIC50,ug ml-1,UO_0000274,,2.0
45432,,,962843,[],CHEMBL878269,Antibacterial activity was determined against clinically isolated vancomycin-B resistant enterococci (VRE) strains (10 strains),F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145781,J Med Chem,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1762,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL613770,Enterococcus sp.,Enterococcus sp.,35783.0,,,MIC90,ug ml-1,UO_0000274,,16.0
45433,,,1047052,[],CHEMBL766814,Inhibition of human Potassium channel HERG expressed in mammalian cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1136167,Bioorg Med Chem Lett,2003.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,172874,=,1,1,=,,IC50,nM,,128824.96,CHEMBL240,Homo sapiens,HERG,9606.0,,,pIC50,,UO_0000065,,3.89
45434,,,1427118,[],CHEMBL832277,Inhibition of human voltage-gated potassium channel subunit Kv11.1 (ERG K+ channel) in open state,F,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142050,Bioorg Med Chem Lett,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,1,http://www.openphacts.org/units/Nanomolar,367552,=,1,1,=,,IC50,nM,,128824.96,CHEMBL240,Homo sapiens,HERG,9606.0,,,Log IC50,,UO_0000065,,-3.89
45435,,,1495458,[],CHEMBL838962,Dissociation constant (pKa) was determined,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,386528,=,1,0,=,,pKa1,,,5.97,CHEMBL2362975,,No relevant target,,,,pKa1,,,,5.97
45436,,,1495459,[],CHEMBL830510,Minimum inhibitory concentration against Streptococcus agalactiae ATCC 13813,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386528,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.25
45437,,,1495460,[],CHEMBL831781,Minimum inhibitory concentration against Streptococcus sanguis ATCC 10556,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386528,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC,ug ml-1,UO_0000274,,0.5
45438,,,1495461,[],CHEMBL830805,Minimum inhibitory concentration against Klebsiella pneumoniae ATCC 10031,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386528,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.008
45439,,,1495462,[],CHEMBL831389,Minimum inhibitory concentration against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386528,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
45440,,,1495463,[],CHEMBL831791,Minimum inhibitory concentration against Pseudomonas aeruginosa ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386528,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
45441,,,1495464,[],CHEMBL831421,Minimum inhibitory concentration against Bacteroides vulgatus ATCC 29327,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386528,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC,ug ml-1,UO_0000274,,0.5
45442,,,1495465,[],CHEMBL836109,Mutant prevention concentration against methicillin resistant Staphylococcus aureus-32 done for 48 h at 37 degree C with compound,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386528,=,1,0,=,,MPC,ug ml-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MPC,ug ml-1,UO_0000274,,8.0
45443,,,1495466,[],CHEMBL836110,Mutant prevention concentration aganist methicillin resistant Staphylococcus aureus-33 done for 48 hr at 37 degree C with compound,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386528,=,1,0,=,,MPC,ug ml-1,,14.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MPC,ug ml-1,UO_0000274,,14.0
45444,,,1495467,[],CHEMBL831471,Mutant prevention concentration aganist methicillin resistant Staphylococcus aureus-5023 done for 48 hr at 37 degree C with compound,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386528,=,1,0,=,,MPC,ug ml-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MPC,ug ml-1,UO_0000274,,8.0
45445,,,1495468,[],CHEMBL838134,Ratio of MPC to MIC aganist methicillin resistant Staphylococcus aureus-32,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,386528,=,1,0,=,,MPC/MIC,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MPC/MIC,,,,2.0
45446,,,1495469,[],CHEMBL838964,Dissociation constant (pKa) was determined,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,386528,=,1,0,=,,pKa2,,,9.82,CHEMBL2362975,,No relevant target,,,,pKa2,,,,9.82
45447,,,1495470,[],CHEMBL838135,Ratio of MPC to MIC against methicillin resistant Staphylococcus aureus-33,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,386528,=,1,0,=,,MPC/MIC,,,3.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MPC/MIC,,,,3.5
45448,,,1495471,[],CHEMBL838136,Ratio of MPC to MIC against methicillin resistant Staphylococcus aureus-5023,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,386528,=,1,0,=,,MPC/MIC,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MPC/MIC,,,,2.0
45449,,,1495472,[],CHEMBL835139,Frequency of resistance emergence for methicillin resistant Staphylococcus aureus-32,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,386528,=,1,0,=,,FRE,,,0.000451,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FRE,,,,0.000451
45450,,,1495473,[],CHEMBL835140,Frequency of resistance emergence for methicillin resistant Staphylococcus aureus-33,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,386528,=,1,0,=,,FRE,,,0.0041,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FRE,,,,0.0041
45451,,,1495474,[],CHEMBL835141,Frequency of resistance emergence for methicillin resistant Staphylococcus aureus-5023,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,386528,=,1,0,=,,FRE,,,3.51e-06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FRE,,,,3.51e-06
45452,,,1495475,[],CHEMBL876455,Partition coefficient (logD2.0),P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,386528,=,1,1,=,,LogD,,,-1.14,CHEMBL2362975,,No relevant target,,,,logD,,,,-1.14
45453,,,1495476,[],CHEMBL827011,Partition coefficient (logD7.4),P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,386528,=,1,1,=,,LogD,,,-0.79,CHEMBL2362975,,No relevant target,,,,logD,,,,-0.79
45454,,,1495477,[],CHEMBL831777,Minimum inhibitory concentration against Staphylococcus aureus ATCC 25923,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386528,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
45455,,,1495478,[],CHEMBL875746,Minimum inhibitory concentration against Staphylococcus haemolyticus ATCC 29970,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386528,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.06
45456,,,1495479,[],CHEMBL830690,Minimum inhibitory concentration against Staphylococcus saprophyticus ATCC 15305,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386528,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,0.25
45457,,,1495480,[],CHEMBL830804,Minimum inhibitory concentration against Enterococcus faecalis ATCC 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386528,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
45458,,,1495481,[],CHEMBL831326,Minimum inhibitory concentration against Streptococcus pneumoniae ATCC 49619,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386528,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
45459,,,1495482,[],CHEMBL830503,Minimum inhibitory concentration against Streptococcus pneumoniae ATCC 6303,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386528,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
45460,,,1495483,[],CHEMBL831794,Minimum inhibitory concentration against Streptococcus pyogenes ATCC 19615,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1141145,J Med Chem,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,386528,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.25
45461,,,1523948,[],CHEMBL829152,Inhibitory concentration against potassium channel HERG,B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1139598,Bioorg Med Chem Lett,2005.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,1,http://www.openphacts.org/units/Nanomolar,395921,=,1,1,=,,IC50,nM,,128824.96,CHEMBL240,Homo sapiens,HERG,9606.0,,,pIC50,,UO_0000065,,3.89
45462,,,1695219,[],CHEMBL865595,Antimicrobial activity against Escherichia coli ATCC 25922,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,441545,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
45463,,,1695256,[],CHEMBL865596,Antimicrobial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,441545,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
45464,,,1695293,[],CHEMBL865597,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 700699,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,441545,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
45465,,,1695312,[],CHEMBL864433,Cytotoxicity against human Hep2 laryngeal carcinoma cell line,F,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,441545,=,1,1,=,,CC50,nM,,67000.0,CHEMBL614735,Homo sapiens,HEp-2,9606.0,,,CC50,uM,UO_0000065,,67.0
45466,,,1695507,[],CHEMBL863775,Inhibitory activity against wild type Escherichia coli gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,"{'bei': '16.78', 'le': '0.32', 'lle': '4.32', 'sei': '7.52'}",CHEMBL31,GATIFLOXACIN,CHEMBL31,6.3,0,http://www.openphacts.org/units/Nanomolar,441545,=,1,1,=,,IC50,nM,,500.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,uM,UO_0000065,,0.5
45467,,,1695523,[],CHEMBL864372,Inhibitory activity against wild type Staphylococcus aureus topoisomerase 4,B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139657,Bioorg Med Chem Lett,2006.0,"{'bei': '15.77', 'le': '0.30', 'lle': '3.94', 'sei': '7.07'}",CHEMBL31,GATIFLOXACIN,CHEMBL31,5.92,0,http://www.openphacts.org/units/Nanomolar,441545,=,1,1,=,,IC50,nM,,1200.0,CHEMBL4088,Staphylococcus aureus,Topoisomerase IV subunit A,1280.0,,,IC50,uM,UO_0000065,,1.2
45468,,,1720690,[],CHEMBL863124,Cytotoxicity against Vero cell line,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1148530,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,491480,>,1,1,>,,IC50,ug.mL-1,,62.5,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,ug ml-1,UO_0000274,,62.5
45469,,,1720710,[],CHEMBL863125,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148530,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,491480,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.2
45470,,,1720730,[],CHEMBL863126,Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148530,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,491480,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,6.25
45471,,,1720767,[],CHEMBL867511,"Activity against Mycobacterium tuberculosis H37Rv infected in CD1 mouse assessed as decrease in bacterial load relative to control in lung at 50 mg/kg, ip",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148530,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,491480,=,1,0,=,,Log10 cfu,,,6.02,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,6.02
45472,,,1720768,[],CHEMBL867513,"Activity against Mycobacterium tuberculosis H37Rv infected in CD1 mouse assessed as decrease in bacterial load relative to control in spleen at 50 mg/kg, ip",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148530,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,491480,=,1,0,=,,Log10 cfu,,,6.24,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,6.24
45473,,,1725280,[],CHEMBL868151,Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147715,Bioorg Med Chem Lett,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,476444,=,1,1,=,,MIC,ug.mL-1,,3.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,3.12
45474,,,1725296,[],CHEMBL868150,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147715,Bioorg Med Chem Lett,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,476444,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.2
45475,,,1725313,[],CHEMBL867488,Inhibition of Mycobacterium tuberculosis DNA gyrase,B,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147715,Bioorg Med Chem Lett,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,476444,=,1,1,=,,IC50,ug.mL-1,,4.0,CHEMBL612545,,Unchecked,,,,IC50,ug ml-1,UO_0000274,,4.0
45476,,,1725360,[],CHEMBL867491,Activity against Mycobacterium tuberculosis ATCC 35801 in CD1 mouse at 50 mg/kg assessed as decrease in bacterial load in lung relative to control,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147715,Bioorg Med Chem Lett,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,476444,=,1,0,=,,Log10 cfu,,,5.82,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,5.82
45477,,,1725361,[],CHEMBL867492,Activity against Mycobacterium tuberculosis ATCC 35801 in CD1 mouse at 50 mg/kg assessed as decrease in bacterial load in spleen relative to control,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147715,Bioorg Med Chem Lett,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,476444,=,1,0,=,,Log10 cfu,,,6.14,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,6.14
45478,,,1775318,[],CHEMBL856671,Inhibition of Escherichia coli gyrase,F,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,6.3,1,http://www.openphacts.org/units/Nanomolar,586692,=,1,1,=,,IC50,nM,,500.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,uM,UO_0000065,,0.5
45479,,,1775328,[],CHEMBL908930,Antibacterial activity against Escherichia coli EC1-10,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
45480,,,1775333,[],CHEMBL856589,Antibacterial activity against Klebsiella pneumonia KP2,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.06
45481,,,1775338,[],CHEMBL856591,Antibacterial activity against Providencia rettgeri PR9,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.5
45482,,,1775343,[],CHEMBL856592,Antibacterial activity against Pseudomonas aeruginosa PA7,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
45483,,,1775348,[],CHEMBL856593,Antibacterial activity against Escherichia coli EC2026,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,<,1,1,<,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
45484,,,1775353,[],CHEMBL856594,Antibacterial activity against Escherichia coli EC2549,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,<,1,1,<,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
45485,,,1775373,[],CHEMBL856595,Antibacterial activity against Haemophilus influenzae HI3542,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.015
45486,,,1775378,[],CHEMBL856596,Antibacterial activity against Moraxella catarrhalis BC-3531,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.03
45487,,,1775383,[],CHEMBL856597,Antibacterial activity against Staphylococcus aureus SA1417,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
45488,,,1775388,[],CHEMBL856598,Antibacterial activity against Staphylococcus aureus UC-76 SA-1,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
45489,,,1775393,[],CHEMBL856599,Antibacterial activity against Staphylococcus aureus SA2552,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
45490,,,1775398,[],CHEMBL855582,Antibacterial activity against Staphylococcus aureus SA2554,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
45491,,,1775403,[],CHEMBL855583,Antibacterial activity against Staphylococcus aureus SA2558,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
45492,,,1775408,[],CHEMBL855584,Antibacterial activity against methicillin-resistant Staphylococcus aureus SA1417,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
45493,,,1775413,[],CHEMBL855585,Antibacterial activity against ciprofolxacin-resistant Staphylococcus aureus SA2017,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
45494,,,1775418,[],CHEMBL856604,Antibacterial activity against Enterococcus faecalis MGH2 EF1-1,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
45495,,,1775423,[],CHEMBL856605,Antibacterial activity against Enterococcus faecalis EF1-3524,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,16.0
45496,,,1775428,[],CHEMBL856606,Antibacterial activity against vancomycin-resistant Enterococcus faecium EF4-3489,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,32.0
45497,,,1775433,[],CHEMBL856607,Antibacterial activity against Streptococcus pneumonia SVI SP3,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
45498,,,1775438,[],CHEMBL856608,Antibacterial activity against quinolone-resistant Streptococcus pneumonia SP3763,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
45499,,,1775443,[],CHEMBL856609,Antibacterial activity against Streptococcus pyogenes C203 SP1-1,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.5
45500,,,1775449,[],CHEMBL856590,Antibacterial activity against Klebsiella pneumonia ESBL KP3729,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137308,J Med Chem,2006.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,586692,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
45501,,,1819118,[],CHEMBL909641,Cytotoxicity against human PC3 cells at 2 ug/ml relative to control,A,,,BAO_0001103,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,625551,=,1,0,=,,Activity,%,,97.6,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,%,UO_0000187,,97.6
45502,,,1829490,[],CHEMBL909642,Cytotoxicity against human PC3 cells at 4 ug/ml relative to control,A,,,BAO_0001103,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,625551,=,1,0,=,,Activity,%,,100.0,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,%,UO_0000187,,100.0
45503,,,1829541,[],CHEMBL909643,Cytotoxicity against human PC3 cells at 16 ug/ml relative to control,A,,,BAO_0001103,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,625551,=,1,0,=,,Activity,%,,96.6,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,%,UO_0000187,,96.6
45504,,Dose-dependent effect,1829542,[],CHEMBL909644,Decrease in IL8 secretion in human PC3 cells,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,625551,,1,0,,,Activity,,,,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,,,,
45505,,,1829543,[],CHEMBL909645,Decrease in IL8 secretion in human PC3 cells at 4 ug/ml,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,625551,=,1,0,=,,Activity,%,,22.0,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,%,UO_0000187,,22.0
45506,,,1829544,[],CHEMBL909646,Decrease in IL8 secretion in human PC3 cells at 16 ug/ml,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,625551,=,1,0,=,,Activity,%,,38.0,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,%,UO_0000187,,38.0
45507,,,1829545,[],CHEMBL909647,Reduction of peptidoglycan-stimulated IL8 secretion in human PC3 cells,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,625551,=,1,0,=,,Activity,%,,42.0,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,%,UO_0000187,,42.0
45508,,,1829546,[],CHEMBL908613,Reduction of Mycoplasma hominis-stimulated IL8 secretion in human PC3 cells,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,625551,=,1,0,=,,Activity,%,,52.0,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,%,UO_0000187,,52.0
45509,,,1829547,[],CHEMBL908614,Suppression of PMA-stimulated IL8 secretion in human PC3 cells,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,625551,=,1,0,=,,Activity,%,,34.0,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,%,UO_0000187,,34.0
45510,,Active,1829548,[],CHEMBL908615,Suppression of TNF alpha-stimulated IL8 secretion in human PC3 cells,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,625551,,1,0,,,Activity,,,,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,,,,
45511,,,1829549,[],CHEMBL908616,Suppression of 0.1 ng/ml LPS-stimulated IL8 secretion in human PC3 cells,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,625551,=,1,0,=,,Activity,%,,19.0,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,%,UO_0000187,,19.0
45512,,,1829550,[],CHEMBL908617,Suppression of 1 ng/ml LPS-stimulated IL8 secretion in human PC3 cells,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,625551,=,1,0,=,,Activity,%,,16.0,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,%,UO_0000187,,16.0
45513,,,1829551,[],CHEMBL908618,Suppression IL8 secretion in human PC3 cells at 16 ug/ml added simultaneously with TNF alpha,F,,,BAO_0001103,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,625551,=,1,0,=,,Activity,%,,37.0,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,%,UO_0000187,,37.0
45514,,,1829552,[],CHEMBL908619,Suppression of TNF alpha-stimulated IL8 secretion in human PC3 cells at 16 ug/ml added 30 mins after stimulation,F,,,BAO_0000201,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,625551,=,1,1,=,,Inhibition,%,,25.0,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Inhibition,%,UO_0000187,,25.0
45515,,Active,1829553,[],CHEMBL908620,Suppression of TNF alpha-stimulated IL8 secretion in human PC3 cells at 16 ug/ml added 60 mins after stimulation,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,625551,,1,0,,,Activity,,,,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,,,,
45516,,Not Active,1829554,[],CHEMBL908621,Inhibition of peptidoglycan-induced NF kappaB activation in human PC3 cells at 16 ug/ml,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,625551,,1,0,,,Activity,,,,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,,,,
45517,,Not Active,1829555,[],CHEMBL909655,Inhibition of Mycoplasma hominis-induced NF kappaB activation in human PC3 cells at 16 ug/ml,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,625551,,1,0,,,Activity,,,,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,,,,
45518,,Not Active,1829556,[],CHEMBL909656,Inhibition of TNF alpha-induced NF kappaB activation in human PC3 cells at 16 ug/ml,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,625551,,1,0,,,Activity,,,,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,,,,
45519,,Active,1829557,[],CHEMBL909657,Inhibition of TNF alpha-stimulated IL8 mRNA expression in human PC3 cells at 16 ug/ml after 48 hrs,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,625551,,1,0,,,Activity,,,,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,,,,
45520,,Active,1829558,[],CHEMBL911419,Suppression of TNF alpha-stimulated IL8 D-240 mutant promoter activity in human PC3 cells at 16 ug/ml dual luciferase reporter assay,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,625551,,1,0,,,Activity,,,,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,,,,
45521,,Active,1829559,[],CHEMBL911420,Suppression of TNF alpha-stimulated IL8 D-188 mutant promoter activity in human PC3 cells at 16 ug/ml dual luciferase reporter assay,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,625551,,1,0,,,Activity,,,,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,,,,
45522,,Not Active,1829560,[],CHEMBL909659,Suppression of TNF alpha-stimulated IL8 D-170 mutant promoter activity in human PC3 cells at 16 ug/ml dual luciferase reporter assay,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,625551,,1,0,,,Activity,,,,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,,,,
45523,,,1829561,[],CHEMBL911421,Decrease in IL8 secretion in human prostatic myofibroblast cells at 4 ug/ml,F,,,BAO_0001103,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,625551,=,1,0,=,,Activity,%,,19.0,CHEMBL612545,,Unchecked,,,,Activity,%,UO_0000187,,19.0
45524,,,1829562,[],CHEMBL911422,Decrease in IL8 secretion in human prostatic myofibroblast cells at 16 ug/ml,F,,,BAO_0001103,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,625551,=,1,0,=,,Activity,%,,50.0,CHEMBL612545,,Unchecked,,,,Activity,%,UO_0000187,,50.0
45525,,Active,1829563,[],CHEMBL911418,Suppression of TNF alpha-stimulated IL8 D-145 mutant promoter activity in human PC3 cells at 16 ug/ml by dual luciferase reporter assay,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,625551,,1,0,,,Activity,,,,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,,,,
45526,,Active,1832949,[],CHEMBL909658,Suppression of TNF alpha-stimulated IL8 promoter activity in human PC3 cells,F,,,BAO_0000375,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142061,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,625551,,1,0,,,Activity,,,,CHEMBL390,Homo sapiens,PC-3,9606.0,,,Activity,,,,
45527,,,1833793,[],CHEMBL908132,Antimicrobial activity against Streptococcus pneumoniae R6,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
45528,,,1833795,[],CHEMBL908133,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
45529,,,1833799,[],CHEMBL908134,Antimicrobial activity agaisnt Streptococcus pneumoniae R6 transformants with parC S79Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
45530,,,1833803,[],CHEMBL908135,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
45531,,,1833807,[],CHEMBL908136,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
45532,,,1833811,[],CHEMBL908137,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA S81Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
45533,,,1833815,[],CHEMBL908138,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
45534,,,1833819,[],CHEMBL908139,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
45535,,,1833823,[],CHEMBL908140,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79Y and gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,>=,1,1,>=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
45536,,,1833827,[],CHEMBL908141,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79Y and gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,>=,1,1,>=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
45537,,,1833831,[],CHEMBL908142,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F and gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,>=,1,1,>=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
45538,,,1833835,[],CHEMBL908143,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC S79F and gyrA S81Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,>=,1,1,>=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
45539,,,1833839,[],CHEMBL908144,Antimicrobial activity agaisnt Streptococcus pneumoniae R6 transformants with parC S79F and gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,>=,1,1,>=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
45540,,,1833843,[],CHEMBL908145,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
45541,,,1833847,[],CHEMBL908146,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA S81Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,>=,1,1,>=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
45542,,,1833851,[],CHEMBL908147,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parC D83Y and gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
45543,,,1833855,[],CHEMBL908148,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA S81F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
45544,,,1833859,[],CHEMBL908149,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA S81Y mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,>=,1,1,>=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
45545,,,1833863,[],CHEMBL908150,Antimicrobial activity against Streptococcus pneumoniae R6 transformants with parE D435N and gyrA E85K mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142188,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625886,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
45546,,,1834932,[],CHEMBL905926,Antibacterial activity against gatifloxacin resistance selected Streptococcus pneumoniae 3009 after 14 passages by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
45547,,,1834936,[],CHEMBL906973,Antibacterial activity against gatifloxacin resistance selected Streptococcus pneumoniae 1076 with ParC S79Y mutation after 20 passages by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
45548,,,1834949,[],CHEMBL908693,"Antibacterial activity against gatifloxacin resistance selected Streptococcus pneumoniae 37 with GyrA S81Y, GyrB E474K and ParC S79Y mutation after 14 passages by macrodilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
45549,,,1834966,[],CHEMBL908694,Antibacterial activity against levofloxacin resistance selected Streptococcus pneumoniae 3009 with GyrA S81Y and ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
45550,,,1834978,[],CHEMBL908695,Antibacterial activity against gatifloxacin resistance selected Streptococcus pneumoniae 3009 after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
45551,,,1834995,[],CHEMBL908696,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3009 with GyrA S81F and ParC D83N mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
45552,,,1835013,[],CHEMBL908697,Antibacterial activity against clarithromycin resistance selected Streptococcus pneumoniae 3009 after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
45553,,,1835044,[],CHEMBL908698,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 1076 with ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
45554,,,1835058,[],CHEMBL908699,Antibacterial activity against gatifloxacin resistance selected Streptococcus pneumoniae 1076 with ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
45555,,,1835071,[],CHEMBL908700,Antibacterial activity against azithromycin resistance selected Streptococcus pneumoniae 1077 with 23S rRNA A2058G mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
45556,,,1835085,[],CHEMBL908701,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3665 with GyrA S81Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
45557,,,1835095,[],CHEMBL908702,Antibacterial activity against clarithromycin resistance selected Streptococcus pneumoniae 3665 after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
45558,,,1835114,[],CHEMBL908703,"Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3676 with GyrA E85G, GyrB S478I and ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
45559,,,1835136,[],CHEMBL908704,Antibacterial activity against clarithromycin resistance selected Streptococcus pneumoniae 3676 after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
45560,,,1835146,[],CHEMBL908705,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 3243 after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
45561,,,1835156,[],CHEMBL908706,Antibacterial activity against azithromycin resistance selected Streptococcus pneumoniae 3243 with L22 insertion 93SFRPRA94 mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
45562,,,1835166,[],CHEMBL908707,Antibacterial activity against clarithromycin resistance selected Streptococcus pneumoniae 3243 with 23S rRNA A2059T mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
45563,,,1835176,[],CHEMBL908708,Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 19 with GyrA S81F mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
45564,,,1835186,[],CHEMBL908709,Antibacterial activity against levofloxacin resistance selected Streptococcus pneumoniae 19 with GyrA S81Y and ParC D83Y mutation after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
45565,,,1835196,[],CHEMBL908127,"Antibacterial activity against moxifloxacin resistance selected Streptococcus pneumoniae 24 with GyrA S81Y, GyrB P413S and ParC S79F mutation after 10 antibiotic-free subcultures by macrodilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
45566,,,1835206,[],CHEMBL908128,Antibacterial activity against azithromycin resistance selected Streptococcus pneumoniae 2527 after 10 antibiotic-free subcultures by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
45567,,,1835216,[],CHEMBL908129,"Antibacterial activity against gatifloxacin resistance selected Streptococcus pneumoniae 37 with GyrA S81Y, GyrB E474K and ParC S79Y mutation after 10 antibiotic-free subcultures by macrodilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
45568,,,1835226,[],CHEMBL908130,Antibacterial activity against Streptococcus pneumoniae assessed as period of suppression of bacterial growth,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Hour,625875,=,1,0,=,,Post Antibiotic Effe,hr,,1.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Post Antibiotic Effe,hr,UO_0000032,,1.7
45569,,,1835811,[],CHEMBL854042,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.03
45570,,,1835826,[],CHEMBL854043,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 gyrA+,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.03
45571,,,1835841,[],CHEMBL854044,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 acrAB::Kan,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
45572,,,1835856,[],CHEMBL854045,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 tolC::Kan,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
45573,,,1835871,[],CHEMBL854046,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 GyrA S83F mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
45574,,,1835886,[],CHEMBL854047,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 gyrA+,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.03
45575,,,1835901,[],CHEMBL854048,Antimicrobial activity against Salmonella enterica serovar Typhimurium GyrA S21-1 acrAB::Kan with GyrA S83F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.03
45576,,,1835916,[],CHEMBL854049,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 tolC::Kan with GyrA S83F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.03
45577,,,1835931,[],CHEMBL854050,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,1.0
45578,,,1835946,[],CHEMBL854051,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 gyrA+ with ParC S80I mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.25
45579,,,1835961,[],CHEMBL854052,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 acrAB::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
45580,,,1835976,[],CHEMBL854053,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 tolC::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
45581,,,1835991,[],CHEMBL854054,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,8.0
45582,,,1836006,[],CHEMBL854140,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 gyrA+ with ParC S80I mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,1.0
45583,,,1836021,[],CHEMBL854141,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 acrAB::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
45584,,,1836036,[],CHEMBL855232,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 tolC::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
45585,,,1836051,[],CHEMBL855233,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,16.0
45586,,,1836066,[],CHEMBL855234,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 gyrA+ with ParC S80I mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,2.0
45587,,,1836081,[],CHEMBL855231,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 acrAB::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
45588,,,1836096,[],CHEMBL855786,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 tolC::Kan with GyrA S83F, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
45589,,,1836111,[],CHEMBL855787,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,4.0
45590,,,1836126,[],CHEMBL855788,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
45591,,,1836141,[],CHEMBL855789,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
45592,,,1836156,[],CHEMBL855790,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 tolC::Kan with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
45593,,,1836171,[],CHEMBL855791,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,4.0
45594,,,1836186,[],CHEMBL855792,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
45595,,,1836201,[],CHEMBL855793,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
45596,,,1836216,[],CHEMBL855794,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 tolC::Kan with GyrA S83F, D87N, parC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
45597,,,1836231,[],CHEMBL855795,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,4.0
45598,,,1836246,[],CHEMBL855796,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
45599,,,1836261,[],CHEMBL855797,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
45600,,,1836276,[],CHEMBL855798,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 tolC::Kan with GyrA S83F, D87N, ParC S80I mutation",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
45601,,,1836291,[],CHEMBL855799,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.25
45602,,,1836306,[],CHEMBL854744,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 gyrA+ with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.03
45603,,,1836321,[],CHEMBL854745,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 acrAB::Kan with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
45604,,,1836335,[],CHEMBL854746,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 tolC::Kan with GyrA D87G mutant,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
45605,,,1836350,[],CHEMBL854747,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 with GyrA S38F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.25
45606,,,1836365,[],CHEMBL854748,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 gyrA+ with GyrA S38F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.06
45607,,,1836380,[],CHEMBL854749,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 acrAB::Kan with GyrA S38F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.12
45608,,,1836395,[],CHEMBL854750,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 tolC::Kan with GyrA S38F mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.03
45609,,,1836410,[],CHEMBL855813,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.12
45610,,,1836425,[],CHEMBL855814,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 gyrA+ with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
45611,,,1836440,[],CHEMBL855815,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 acrAB::Kan with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
45612,,,1836455,[],CHEMBL855816,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 tolC::Kan with GyrA D87G mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142136,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625585,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.015
45613,,,1836913,[],CHEMBL856454,Antibacterial activity against Streptococcus pneumoniae 3009 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
45614,,,1836921,[],CHEMBL856455,Antibacterial activity against Streptococcus pneumoniae 1076 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
45615,,,1836934,[],CHEMBL856463,Antibacterial activity against Streptococcus pneumoniae 37 by macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142186,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625875,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
45616,,,1864888,[],CHEMBL916588,Antibacterial activity against oxacillin-susceptible Staphylococcus aureus,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.125
45617,,,1864889,[],CHEMBL916588,Antibacterial activity against oxacillin-susceptible Staphylococcus aureus,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.125
45618,,,1864896,[],CHEMBL916589,Antibacterial activity against oxacillin-resistant Staphylococcus aureus,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,4.0
45619,,,1864897,[],CHEMBL916589,Antibacterial activity against oxacillin-resistant Staphylococcus aureus,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
45620,,,1864904,[],CHEMBL916590,Antibacterial activity against oxacillin and levofloxacin-resistant Staphylococcus aureus,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,8.0
45621,,,1864905,[],CHEMBL916590,Antibacterial activity against oxacillin and levofloxacin-resistant Staphylococcus aureus,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,16.0
45622,,,1864911,[],CHEMBL916591,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
45623,,,1864916,[],CHEMBL916594,Antibacterial activity against Staphylococcus haemolyticus,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC50,ug ml-1,UO_0000274,,0.125
45624,,,1864917,[],CHEMBL916594,Antibacterial activity against Staphylococcus haemolyticus,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,4.0
45625,,,1864924,[],CHEMBL916595,Antibacterial activity against Staphylococcus saprophyticus,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45626,,,1864925,[],CHEMBL916595,Antibacterial activity against Staphylococcus saprophyticus,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC90,ug ml-1,UO_0000274,,0.25
45627,,,1864931,[],CHEMBL916596,Antibacterial activity against Staphylococcus warneri,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,MIC,ug ml-1,UO_0000274,,0.125
45628,,,1864936,[],CHEMBL916597,Antibacterial activity against Alloiococcus otitidis,F,,,BAO_0003035,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.06
45629,,,1864937,[],CHEMBL916597,Antibacterial activity against Alloiococcus otitidis,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.06
45630,,,1864944,[],CHEMBL916580,Antibacterial activity against Streptococcus pyogenes,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45631,,,1864945,[],CHEMBL916580,Antibacterial activity against Streptococcus pyogenes,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.5
45632,,,1864952,[],CHEMBL916598,Antibacterial activity against Streptococcus agalactiae,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45633,,,1864953,[],CHEMBL916598,Antibacterial activity against Streptococcus agalactiae,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,0.25
45634,,,1864960,[],CHEMBL916599,Antibacterial activity against Streptococcus bovis,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC50,ug ml-1,UO_0000274,,1.0
45635,,,1864961,[],CHEMBL916599,Antibacterial activity against Streptococcus bovis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC90,ug ml-1,UO_0000274,,1.0
45636,,,1864968,[],CHEMBL916600,Antibacterial activity against Streptococcus sanguis,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC50,ug ml-1,UO_0000274,,0.5
45637,,,1864969,[],CHEMBL916600,Antibacterial activity against Streptococcus sanguis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC90,ug ml-1,UO_0000274,,0.5
45638,,,1864976,[],CHEMBL916601,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45639,,,1864977,[],CHEMBL916601,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
45640,,,1864984,[],CHEMBL916602,Antibacterial activity against penicillin-intermediate resistant Streptococcus pneumoniae,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45641,,,1864985,[],CHEMBL916602,Antibacterial activity against penicillin-intermediate resistant Streptococcus pneumoniae,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
45642,,,1864992,[],CHEMBL916603,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45643,,,1864993,[],CHEMBL916603,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
45644,,,1865000,[],CHEMBL916604,Antibacterial activity against levofloxacin-resistant Streptococcus pneumoniae,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,4.0
45645,,,1865001,[],CHEMBL916604,Antibacterial activity against levofloxacin-resistant Streptococcus pneumoniae,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
45646,,,1865008,[],CHEMBL916605,Antibacterial activity against Enterococcus faecalis,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,8.0
45647,,,1865009,[],CHEMBL916605,Antibacterial activity against Enterococcus faecalis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,16.0
45648,,,1865015,[],CHEMBL916606,Antibacterial activity against VanA-resistant Enterococcus faecalis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,8.0
45649,,,1865020,[],CHEMBL916045,Antibacterial activity against VanB-resistant Enterococcus faecalis,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,8.0
45650,,,1865021,[],CHEMBL916045,Antibacterial activity against VanB-resistant Enterococcus faecalis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,16.0
45651,,,1865027,[],CHEMBL916046,Antibacterial activity against beta-lactamase positive Enterococcus faecalis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
45652,,,1865032,[],CHEMBL916047,Antibacterial activity against Enterococcus faecium,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,8.0
45653,,,1865033,[],CHEMBL916047,Antibacterial activity against Enterococcus faecium,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,64.0
45654,,,1865040,[],CHEMBL916048,Antibacterial activity against VanA-resistant Enterococcus faecium,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,32.0
45655,,,1865041,[],CHEMBL916048,Antibacterial activity against VanA-resistant Enterococcus faecium,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,64.0
45656,,,1865047,[],CHEMBL916049,Antibacterial activity against VanB-resistant Enterococcus faecium,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,2.0
45657,,,1865052,[],CHEMBL916050,Antibacterial activity against Enterococcus casseliflavus,F,,,BAO_0003035,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL4523080,Enterococcus casseliflavus,Enterococcus casseliflavus,37734.0,,,MIC50,ug ml-1,UO_0000274,,0.5
45658,,,1865053,[],CHEMBL916050,Antibacterial activity against Enterococcus casseliflavus,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL4523080,Enterococcus casseliflavus,Enterococcus casseliflavus,37734.0,,,MIC90,ug ml-1,UO_0000274,,1.0
45659,,,1865060,[],CHEMBL916051,Antibacterial activity against Enterococcus gallinarum,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL613817,Enterococcus gallinarum,Enterococcus gallinarum,1353.0,,,MIC50,ug ml-1,UO_0000274,,0.5
45660,,,1865061,[],CHEMBL916051,Antibacterial activity against Enterococcus gallinarum,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL613817,Enterococcus gallinarum,Enterococcus gallinarum,1353.0,,,MIC90,ug ml-1,UO_0000274,,1.0
45661,,,1865068,[],CHEMBL916052,Antibacterial activity against Listeria monocytogenes,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC50,ug ml-1,UO_0000274,,0.5
45662,,,1865069,[],CHEMBL916052,Antibacterial activity against Listeria monocytogenes,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC90,ug ml-1,UO_0000274,,1.0
45663,,,1865076,[],CHEMBL916053,Antibacterial activity against Corynebacterium jeikeium,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL613351,Corynebacterium jeikeium,Corynebacterium jeikeium,38289.0,,,MIC50,ug ml-1,UO_0000274,,0.125
45664,,,1865077,[],CHEMBL916053,Antibacterial activity against Corynebacterium jeikeium,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL613351,Corynebacterium jeikeium,Corynebacterium jeikeium,38289.0,,,MIC90,ug ml-1,UO_0000274,,0.5
45665,,,1865084,[],CHEMBL916054,Antibacterial activity against Corynebacterium sp.,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL613081,Corynebacterium sp.,Corynebacterium sp.,1720.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45666,,,1865085,[],CHEMBL916054,Antibacterial activity against Corynebacterium sp.,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL613081,Corynebacterium sp.,Corynebacterium sp.,1720.0,,,MIC90,ug ml-1,UO_0000274,,32.0
45667,,,1865092,[],CHEMBL916055,Antibacterial activity against beta-lactamase negative Haemophilus influenzae,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,0.008
45668,,,1865093,[],CHEMBL916055,Antibacterial activity against beta-lactamase negative Haemophilus influenzae,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.015
45669,,,1865100,[],CHEMBL916056,Antibacterial activity against beta-lactamase positive Haemophilus influenzae,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,0.015
45670,,,1865101,[],CHEMBL916056,Antibacterial activity against beta-lactamase positive Haemophilus influenzae,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.015
45671,,,1865107,[],CHEMBL916057,Antibacterial activity against Legionella pneumophila,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.008,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,,MIC50,ug ml-1,UO_0000274,,0.008
45672,,,1865108,[],CHEMBL916057,Antibacterial activity against Legionella pneumophila,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.008,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,,MIC90,ug ml-1,UO_0000274,,0.008
45673,,,1865114,[],CHEMBL916058,Antibacterial activity against beta-lactamase negative Moraxella catarrhalis,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC50,ug ml-1,UO_0000274,,0.06
45674,,,1865115,[],CHEMBL916058,Antibacterial activity against beta-lactamase negative Moraxella catarrhalis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC90,ug ml-1,UO_0000274,,0.06
45675,,,1865121,[],CHEMBL916059,Antibacterial activity against beta-lactamase positive Moraxella catarrhalis,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC50,ug ml-1,UO_0000274,,0.03
45676,,,1865122,[],CHEMBL916059,Antibacterial activity against beta-lactamase positive Moraxella catarrhalis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC90,ug ml-1,UO_0000274,,0.06
45677,,,1865128,[],CHEMBL916060,Antibacterial activity against Neisseria gonorrhoeae,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.004,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC50,ug ml-1,UO_0000274,,0.004
45678,,,1865129,[],CHEMBL916060,Antibacterial activity against Neisseria gonorrhoeae,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.008,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC90,ug ml-1,UO_0000274,,0.008
45679,,,1865136,[],CHEMBL916061,Antibacterial activity against Citrobacter diversus,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,MIC50,ug ml-1,UO_0000274,,0.03
45680,,,1865137,[],CHEMBL916061,Antibacterial activity against Citrobacter diversus,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,MIC90,ug ml-1,UO_0000274,,0.06
45681,,,1865142,[],CHEMBL916062,Antibacterial activity against Citrobacter freundii,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45682,,,1865143,[],CHEMBL916062,Antibacterial activity against Citrobacter freundii,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC90,ug ml-1,UO_0000274,,16.0
45683,,,1865149,[],CHEMBL916063,Antibacterial activity against Enterobacter aerogenes,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC50,ug ml-1,UO_0000274,,1.0
45684,,,1865150,[],CHEMBL916063,Antibacterial activity against Enterobacter aerogenes,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC90,ug ml-1,UO_0000274,,32.0
45685,,,1865157,[],CHEMBL916064,Antibacterial activity against Enterobacter cloacae,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC50,ug ml-1,UO_0000274,,0.06
45686,,,1865158,[],CHEMBL916064,Antibacterial activity against Enterobacter cloacae,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC90,ug ml-1,UO_0000274,,1.0
45687,,,1865164,[],CHEMBL916065,Antibacterial activity against Escherichia coli,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,0.03
45688,,,1865165,[],CHEMBL916065,Antibacterial activity against Escherichia coli,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,1.0
45689,,,1865172,[],CHEMBL916066,Antibacterial activity against Klebsiella oxytoca,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC50,ug ml-1,UO_0000274,,0.03
45690,,,1865173,[],CHEMBL916066,Antibacterial activity against Klebsiella oxytoca,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC90,ug ml-1,UO_0000274,,1.0
45691,,,1865179,[],CHEMBL916067,Antibacterial activity against Klebsiella pneumoniae,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,0.06
45692,,,1865180,[],CHEMBL916067,Antibacterial activity against Klebsiella pneumoniae,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,0.5
45693,,,1865187,[],CHEMBL916068,Antibacterial activity against beta-lactamase positive Klebsiella pneumoniae,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,1.0
45694,,,1865188,[],CHEMBL916068,Antibacterial activity against beta-lactamase positive Klebsiella pneumoniae,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,16.0
45695,,,1865195,[],CHEMBL916069,Antibacterial activity against Morganella morganii,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45696,,,1865196,[],CHEMBL916069,Antibacterial activity against Morganella morganii,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC90,ug ml-1,UO_0000274,,32.0
45697,,,1865203,[],CHEMBL916070,Antibacterial activity against Proteus mirabilis,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45698,,,1865204,[],CHEMBL916070,Antibacterial activity against Proteus mirabilis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC90,ug ml-1,UO_0000274,,4.0
45699,,,1865210,[],CHEMBL916072,Antibacterial activity against Proteus vulgaris,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.06
45700,,,1865215,[],CHEMBL916073,Antibacterial activity against Salmonella enterica serovar Paratyphi,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,,MIC90,ug ml-1,UO_0000274,,0.06
45701,,,1865223,[],CHEMBL916074,Antibacterial activity against Salmonella enterica serovar Typhimurium,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC50,ug ml-1,UO_0000274,,0.03
45702,,,1865224,[],CHEMBL916074,Antibacterial activity against Salmonella enterica serovar Typhimurium,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC90,ug ml-1,UO_0000274,,0.06
45703,,,1865231,[],CHEMBL916075,Antibacterial activity against Salmonella enterica serovar Typhi,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC50,ug ml-1,UO_0000274,,0.03
45704,,,1865232,[],CHEMBL916075,Antibacterial activity against Salmonella enterica serovar Typhi,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC90,ug ml-1,UO_0000274,,0.06
45705,,,1865241,[],CHEMBL916076,Antibacterial activity against Shigella dysenteriae,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,,MIC50,ug ml-1,UO_0000274,,0.03
45706,,,1865242,[],CHEMBL916076,Antibacterial activity against Shigella dysenteriae,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,,MIC90,ug ml-1,UO_0000274,,0.06
45707,,,1865249,[],CHEMBL916077,Antibacterial activity against Shigella flexneri,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,,MIC50,ug ml-1,UO_0000274,,0.03
45708,,,1865250,[],CHEMBL916077,Antibacterial activity against Shigella flexneri,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,,MIC90,ug ml-1,UO_0000274,,0.06
45709,,,1865257,[],CHEMBL916078,Antibacterial activity against Shigella sonnei,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,,MIC50,ug ml-1,UO_0000274,,0.03
45710,,,1865258,[],CHEMBL916078,Antibacterial activity against Shigella sonnei,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,,MIC90,ug ml-1,UO_0000274,,0.06
45711,,,1865265,[],CHEMBL916079,Antibacterial activity against Serratia marcescens,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45712,,,1865266,[],CHEMBL916079,Antibacterial activity against Serratia marcescens,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC90,ug ml-1,UO_0000274,,4.0
45713,,,1865273,[],CHEMBL916080,Antibacterial activity against Acinetobacter sp.,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,,MIC50,ug ml-1,UO_0000274,,0.03
45714,,,1865274,[],CHEMBL916080,Antibacterial activity against Acinetobacter sp.,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,,MIC90,ug ml-1,UO_0000274,,16.0
45715,,,1865281,[],CHEMBL916081,Antibacterial activity against Burkholderia cepacia,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC50,ug ml-1,UO_0000274,,4.0
45716,,,1865282,[],CHEMBL916081,Antibacterial activity against Burkholderia cepacia,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC90,ug ml-1,UO_0000274,,16.0
45717,,,1865289,[],CHEMBL916082,Antibacterial activity against Pseudomonas aeruginosa,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,1.0
45718,,,1865290,[],CHEMBL916082,Antibacterial activity against Pseudomonas aeruginosa,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,64.0
45719,,,1865298,[],CHEMBL916083,Antibacterial activity against Stenotrophomonas maltophilia,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC50,ug ml-1,UO_0000274,,1.0
45720,,,1865299,[],CHEMBL916083,Antibacterial activity against Stenotrophomonas maltophilia,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC90,ug ml-1,UO_0000274,,8.0
45721,,,1865306,[],CHEMBL916586,Antibacterial activity against Bacteroides fragilis,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC50,ug ml-1,UO_0000274,,1.0
45722,,,1865307,[],CHEMBL916586,Antibacterial activity against Bacteroides fragilis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC90,ug ml-1,UO_0000274,,8.0
45723,,,1865314,[],CHEMBL916587,Antibacterial activity against Bacteroides ovatus,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,,MIC50,ug ml-1,UO_0000274,,4.0
45724,,,1865315,[],CHEMBL916587,Antibacterial activity against Bacteroides ovatus,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,,MIC90,ug ml-1,UO_0000274,,16.0
45725,,,1865322,[],CHEMBL916585,Antibacterial activity against Bacteroides thetaiotaomicron,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC50,ug ml-1,UO_0000274,,4.0
45726,,,1865323,[],CHEMBL916585,Antibacterial activity against Bacteroides thetaiotaomicron,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC90,ug ml-1,UO_0000274,,16.0
45727,,,1865330,[],CHEMBL916584,Antibacterial activity against Clostridium difficile,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC50,ug ml-1,UO_0000274,,0.5
45728,,,1865331,[],CHEMBL916584,Antibacterial activity against Clostridium difficile,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC90,ug ml-1,UO_0000274,,0.5
45729,,,1865339,[],CHEMBL916581,Antibacterial activity against Clostridium perfringens,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC50,ug ml-1,UO_0000274,,0.5
45730,,,1865340,[],CHEMBL916581,Antibacterial activity against Clostridium perfringens,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC90,ug ml-1,UO_0000274,,0.5
45731,,,1865346,[],CHEMBL916582,Antibacterial activity against Fusobacterium nucleatum,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,,MIC,ug ml-1,UO_0000274,,0.015
45732,,,1865351,[],CHEMBL916583,Antibacterial activity against Fusobacterium necrophorum,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,,MIC,ug ml-1,UO_0000274,,0.015
45733,,,1865355,[],CHEMBL916085,Antibacterial activity against Fusobacterium sp.,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL612690,Fusobacterium sp.,Fusobacterium sp.,68766.0,,,MIC,ug ml-1,UO_0000274,,0.015
45734,,,1865359,[],CHEMBL916086,Antibacterial activity against Peptostreptococcus anaerobius,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC,ug ml-1,UO_0000274,,0.06
45735,,,1865363,[],CHEMBL916087,Antibacterial activity against Peptostreptococcus asaccharolyticus,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,,MIC,ug ml-1,UO_0000274,,0.06
45736,,,1865367,[],CHEMBL916088,Antibacterial activity against Peptostreptococcus magnus,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,,MIC,ug ml-1,UO_0000274,,0.06
45737,,,1865371,[],CHEMBL917494,Antibacterial activity against Peptostreptococcus prevotii,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,,MIC,ug ml-1,UO_0000274,,0.06
45738,,,1865376,[],CHEMBL917495,Antibacterial activity against Prevotella bivia,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45739,,,1865377,[],CHEMBL917495,Antibacterial activity against Prevotella bivia,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,,MIC90,ug ml-1,UO_0000274,,0.5
45740,,,1865384,[],CHEMBL917496,Antibacterial activity against Prevotella buccae,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45741,,,1865385,[],CHEMBL917496,Antibacterial activity against Prevotella buccae,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,,MIC90,ug ml-1,UO_0000274,,0.5
45742,,,1865393,[],CHEMBL917497,Antibacterial activity against Prevotella corporis,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL615061,Prevotella corporis,Prevotella corporis,28128.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45743,,,1865394,[],CHEMBL917497,Antibacterial activity against Prevotella corporis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL615061,Prevotella corporis,Prevotella corporis,28128.0,,,MIC90,ug ml-1,UO_0000274,,0.5
45744,,,1865401,[],CHEMBL917498,Antibacterial activity against Prevotella melaninogenica,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45745,,,1865402,[],CHEMBL917498,Antibacterial activity against Prevotella melaninogenica,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,,MIC90,ug ml-1,UO_0000274,,0.5
45746,,,1865410,[],CHEMBL917499,Antibacterial activity against Prevotella oralis,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612687,Hoylesella oralis,Hoylesella oralis,28134.0,,,MIC50,ug ml-1,UO_0000274,,0.25
45747,,,1865411,[],CHEMBL917499,Antibacterial activity against Prevotella oralis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612687,Hoylesella oralis,Hoylesella oralis,28134.0,,,MIC90,ug ml-1,UO_0000274,,0.5
45748,,,1865418,[],CHEMBL917500,Antibacterial activity against Prevotella sp.,F,,,BAO_0003035,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.25
45749,,,1865419,[],CHEMBL917500,Antibacterial activity against Prevotella sp.,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.5
45750,,,1865427,[],CHEMBL917501,Antibacterial activity against Propionibacterium acnes,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC50,ug ml-1,UO_0000274,,1.0
45751,,,1865428,[],CHEMBL917501,Antibacterial activity against Propionibacterium acnes,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC90,ug ml-1,UO_0000274,,8.0
45752,,,1865435,[],CHEMBL917502,Antibacterial activity against Neisseria meningitidis,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.004,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,MIC50,ug ml-1,UO_0000274,,0.004
45753,,,1865436,[],CHEMBL917502,Antibacterial activity against Neisseria meningitidis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.008,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,MIC90,ug ml-1,UO_0000274,,0.008
45754,,,1865443,[],CHEMBL917503,Antibacterial activity against Streptococcus salivarius,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,,MIC50,ug ml-1,UO_0000274,,0.5
45755,,,1865444,[],CHEMBL917503,Antibacterial activity against Streptococcus salivarius,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,,MIC90,ug ml-1,UO_0000274,,0.5
45756,,,1865451,[],CHEMBL917504,Antibacterial activity against Streptococcus mitis,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC50,ug ml-1,UO_0000274,,0.5
45757,,,1865452,[],CHEMBL917504,Antibacterial activity against Streptococcus mitis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC90,ug ml-1,UO_0000274,,0.5
45758,,,1865459,[],CHEMBL917505,Antibacterial activity against Streptococcus viridans,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC50,ug ml-1,UO_0000274,,0.5
45759,,,1865460,[],CHEMBL917505,Antibacterial activity against Streptococcus viridans,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC90,ug ml-1,UO_0000274,,0.5
45760,,,1865496,[],CHEMBL916592,Antibacterial activity against oxacillin-susceptible Staphylococcus epidermidis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
45761,,,1865545,[],CHEMBL916084,Antibacterial activity against Actinomyces sp.,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613763,Actinomyces sp.,Actinomyces sp.,29317.0,,,MIC,ug ml-1,UO_0000274,,0.125
45762,,,1865768,[],CHEMBL916593,Antibacterial activity against oxacillin-resistant Staphylococcus epidermidis,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,2.0
45763,,,1865769,[],CHEMBL916593,Antibacterial activity against oxacillin-resistant Staphylococcus epidermidis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,32.0
45764,,,1865770,[],CHEMBL916073,Antibacterial activity against Salmonella enterica serovar Paratyphi,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,,MIC50,ug ml-1,UO_0000274,,0.03
45765,,,1866146,[],CHEMBL916555,Antimicrobial activity against Escherichia coli qnrA1 producing urinary specimen isolate 13.52 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146202,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634770,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
45766,,,1866161,[],CHEMBL916556,Antimicrobial activity against streptomycin-resistant Escherichia coli J53 transconjugant with qnrA1 producing urinary specimen isolate 13.52 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146202,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634770,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
45767,,,1866176,[],CHEMBL916557,Antimicrobial activity against streptomycin-resistant Escherichia coli J53 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146202,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634770,=,1,1,=,,MIC,ug.mL-1,,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.012
45768,,,1868435,[],CHEMBL917518,Antibacterial activity against Salmonella enterica serovar Enteritidis,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,,MIC50,ug ml-1,UO_0000274,,0.03
45769,,,1868436,[],CHEMBL917518,Antibacterial activity against Salmonella enterica serovar Enteritidis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,,MIC90,ug ml-1,UO_0000274,,0.06
45770,,,1868443,[],CHEMBL917519,Antimicrobial activity against Bacteroides distasonis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,MIC90,ug ml-1,UO_0000274,,16.0
45771,,,1868444,[],CHEMBL917519,Antimicrobial activity against Bacteroides distasonis,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147105,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634908,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,MIC50,ug ml-1,UO_0000274,,4.0
45772,,,1868996,[],CHEMBL914159,Peak free concentration at 400 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,0,=,,Activity,ug ml-1,,2.79,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,2.79
45773,,,1868997,[],CHEMBL914158,Peak free concentration at 200 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,0,=,,Activity,ug ml-1,,1.38,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,1.38
45774,,,1868998,[],CHEMBL914157,Peak free concentration at 175 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,0,=,,Activity,ug ml-1,,1.22,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,1.22
45775,,,1868999,[],CHEMBL914156,Peak free concentration at 150 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,0,=,,Activity,ug ml-1,,1.13,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,1.13
45776,,,1869010,[],CHEMBL914730,Peak free concentration at 100 mg/24 hrs regimen in vitro PK model,A,,,BAO_0000181,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,0,=,,Activity,ug ml-1,,0.71,CHEMBL612558,,ADMET,,,,Activity,ug ml-1,UO_0000274,,0.71
45777,,,1869776,[],CHEMBL914170,Half life at 100 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Hour,634946,=,1,1,=,,T1/2,hr,,7.65,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,7.65
45778,,,1869785,[],CHEMBL914171,Half life at 150 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Hour,634946,=,1,1,=,,T1/2,hr,,8.16,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,8.16
45779,,,1869796,[],CHEMBL914172,Half life at 200 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Hour,634946,=,1,1,=,,T1/2,hr,,8.65,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,8.65
45780,,,1869804,[],CHEMBL914185,Half life at 175 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Hour,634946,=,1,1,=,,T1/2,hr,,7.57,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,7.57
45781,,,1869810,[],CHEMBL914173,Half life at 400 mg/24 hrs regimen in vitro PK model,A,,,BAO_0002115,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Hour,634946,=,1,1,=,,T1/2,hr,,8.01,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,8.01
45782,,,1869949,[],CHEMBL915685,Bactericidal activity against Staphylococcus aureus ATCC 49619 with Parc S79Y mutation at fAUC/MIC of 35 after 24 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.38
45783,,,1869957,[],CHEMBL915686,Bactericidal activity against Staphylococcus aureus ATCC 49619 with Parc S79Y mutation and gyrA S81F mutation at fAUC/MIC of 35 after 48 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,6.0
45784,,,1869958,[],CHEMBL915687,Bactericidal activity against Staphylococcus aureus ATCC 49619 with Parc S79Y mutation and gyrA S81F mutation at fAUC/MIC of 35 after 72 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,6.0
45785,,,1869959,[],CHEMBL915688,Bactericidal activity against Staphylococcus aureus ATCC 49619 with Parc S79Y mutation and gyrA S81F mutation at fAUC/MIC of 35 after 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,8.0
45786,,,1869960,[],CHEMBL915689,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 60 after 24 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
45787,,,1869961,[],CHEMBL915690,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 60 after 48 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
45788,,,1869962,[],CHEMBL915691,Bactericidal activity against Staphylococcus aureus ATCC 49619 with parC S79Y mutation at fAUC/MIC of 60 after 72 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.75
45789,,,1869963,[],CHEMBL915692,Bactericidal activity against Staphylococcus aureus ATCC 49619 with S79Y Parc mutation and S81F gyrA mutation at fAUC/MIC of 60 after 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,4.0
45790,,,1869964,[],CHEMBL915693,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 66 after 24 to 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.19
45791,,,1869965,[],CHEMBL915694,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 67 after 24 to 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.19
45792,,,1869966,[],CHEMBL915695,Bactericidal activity against Staphylococcus aureus ATCC 49619 at fAUC/MIC of 144 after 24 to 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.19
45793,,,1869967,[],CHEMBL915087,Bactericidal activity against Staphylococcus aureus BSP-2443 at fAUC/MIC of 51 after 24 to 48 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
45794,,,1869968,[],CHEMBL915088,"Bactericidal activity against Staphylococcus aureus BSP-2443 with parC S52G, N91D mutation at fAUC/MIC of 51 after 72 hrs in pharmacodynamic model",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.38
45795,,,1869969,[],CHEMBL915089,"Bactericidal activity against Staphylococcus aureus BSP-2443 with parC S52G, N91D mutation and gyrA S114G mutation at fAUC/MIC of 51 after 96 hrs in pharmacodynamic model",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,3.0
45796,,,1869970,[],CHEMBL915090,Bactericidal activity against Staphylococcus aureus BSP-2443 at fAUC/MIC of 62 after 24 to 96 hrs in pharmacodynamic model,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
45797,,,1870018,[],CHEMBL914153,Susceptibility of Streptococcus pneumoniae ATCC 49619 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.025
45798,,,1870021,[],CHEMBL914732,Susceptibility of Streptococcus pneumoniae BSP-2443 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634946,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.025
45799,,Not Active,1870022,[],CHEMBL916090,Effect on efflux-mediatated resistance of Staphylococcus aureus ATCC 49619 mutant,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,634946,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
45800,,,1870044,[],CHEMBL914187,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 100 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,634946,=,1,0,=,,fAUC/MIC,,,35.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,35.0
45801,,,1870045,[],CHEMBL914188,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 150 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,634946,=,1,0,=,,fAUC/MIC,,,60.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,60.0
45802,,,1870046,[],CHEMBL914189,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 175 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,634946,=,1,0,=,,fAUC/MIC,,,66.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,66.0
45803,,,1870047,[],CHEMBL914190,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 200 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,634946,=,1,0,=,,fAUC/MIC,,,67.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,67.0
45804,,,1870049,[],CHEMBL914191,fAUC/MIC ratio of Staphylococcus aureus ATCC 49610 at 400 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,634946,=,1,0,=,,fAUC/MIC,,,144.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,144.0
45805,,,1870065,[],CHEMBL915673,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 198 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,634946,=,1,0,=,,fAUC/MIC,,,51.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,51.0
45806,,,1870066,[],CHEMBL915675,fAUC/MIC ratio of Staphylococcus aureus BSP-2443 at 235 mg,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1147116,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,634946,=,1,0,=,,fAUC/MIC,,,62.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fAUC/MIC,,,,62.0
45807,,,1955400,[],CHEMBL891393,Antibacterial activity against quinoline-susceptible methicillin-resistant Staphylococcus aureus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647141,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
45808,,,1955415,[],CHEMBL891394,Antibacterial activity against quinoline-intermediate methicillin-resistant Staphylococcus aureus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647141,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
45809,,,1955430,[],CHEMBL891395,Antibacterial activity against quinoline-resistant methicillin-resistant Staphylococcus aureus by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647141,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
45810,,,1955445,[],CHEMBL891396,Antibacterial activity against Enterococcus faecalis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647141,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,1.0
45811,,,1955460,[],CHEMBL891397,Antibacterial activity against Streptococcus pneumoniae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647141,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
45812,,,1955475,[],CHEMBL891398,Antibacterial activity against Moraxella catarrhalis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647141,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.063
45813,,,1955490,[],CHEMBL891399,Antibacterial activity against Haemophilus influenzae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647141,<=,1,1,<=,,MIC,ug.mL-1,,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.008
45814,,,1955505,[],CHEMBL891400,Antibacterial activity against Escherichia coli without AcrAB efflux system by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647141,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.063
45815,,,1955520,[],CHEMBL891401,Antibacterial activity against Escherichia coli with AcrAB efflux system by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647141,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.063
45816,,,1955535,[],CHEMBL891402,Antibacterial activity against Pseudomonas aeruginosa by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1146325,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,647141,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
45817,,,1965161,[],CHEMBL897189,Antibacterial activity against Escherichia coli ATCC 25922 by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148855,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,657187,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
45818,,,1965175,[],CHEMBL897183,Antibacterial activity against Bacillus subtilis ATCC 6633 by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148855,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,657187,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.12
45819,,,1965192,[],CHEMBL897184,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148855,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,657187,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
45820,,,1965209,[],CHEMBL897186,Antibacterial activity against Enterococcus faecalis ATCC 29212 by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148855,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,657187,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
45821,,,1965226,[],CHEMBL897185,Antibacterial activity against Staphylococcus aureus ATCC 33591 by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148855,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,657187,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
45822,,,1965257,[],CHEMBL897187,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148855,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,657187,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
45823,,,1965260,[],CHEMBL897188,Antibacterial activity against Klebsiella pneumoniae ATCC 10031 by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148855,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,657187,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.12
45824,,,1965277,[],CHEMBL897190,Antibacterial activity against Staphylococcus aureus ATCC 25923 by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148855,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,657187,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
45825,,,1965291,[],CHEMBL897191,Antibacterial activity against Staphylococcus aureus ATCC 29213 by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148855,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,657187,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
45826,,,1965307,[],CHEMBL897192,Antibacterial activity against Staphylococcus aureus ATCC 33592 by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148855,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,657187,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
45827,,,1965326,[],CHEMBL897193,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148855,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,657187,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
45828,,,1965333,[],CHEMBL897194,Antibacterial activity against linezolid-resistant Staphylococcus aureus NRS 119 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148855,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,657187,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
45829,,,1965347,[],CHEMBL897195,Antibacterial activity against Enterococcus faecalis ATCC 14506 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148855,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,657187,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
45830,,,1965360,[],CHEMBL897196,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 700802 by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148855,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,657187,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
45831,,,1965373,[],CHEMBL897197,Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 700221 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148855,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,657187,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,16.0
45832,,,1965386,[],CHEMBL897198,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 700904 by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1148855,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,657187,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
45833,,,2002065,[],CHEMBL900652,Cytotoxicity against Vero cells after 72 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1138270,J Med Chem,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,666359,>,1,1,>,,IC50,nM,,155300.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,uM,UO_0000065,,155.3
45834,,,2002120,[],CHEMBL901695,Antimycobacterial activity against multi-drug-resistant Mycobacterium tuberculosis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138270,J Med Chem,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,666359,=,1,1,=,,MIC,nM,,8340.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,8.34
45835,,,2002171,[],CHEMBL901697,Antimicrobial activity against Mycobacterium smegmatis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138270,J Med Chem,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,666359,=,1,1,=,,MIC,nM,,2080.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,uM,UO_0000065,,2.08
45836,,,2002222,[],CHEMBL901696,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138270,J Med Chem,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,666359,=,1,1,=,,MIC,nM,,1040.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,1.04
45837,,,2002274,[],CHEMBL901698,"Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35801 infected CD1 mouse assessed as lung bacterial count at 50 mg/kg, ip after 35 days post infection",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138270,J Med Chem,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,666359,=,1,0,=,,Log10 cfu,,,6.02,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,6.02
45838,,,2002276,[],CHEMBL901700,"Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35801 infected CD1 mouse assessed as spleen bacterial count at 50 mg/kg, ip after 35 days post infection",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138270,J Med Chem,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,666359,=,1,0,=,,Log10 cfu,,,6.92,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,6.92
45839,,,2043824,[],CHEMBL940996,Antitubercular activity against Mycobacterium tuberculosis H37Rv,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139821,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,678337,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.1
45840,,,2051123,[],CHEMBL941681,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1140558,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,680750,=,1,1,=,,MIC,nM,,2080.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,2.08
45841,,,2051140,[],CHEMBL941682,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1140558,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,680750,=,1,1,=,,MIC,nM,,8340.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,8.34
45842,,,2051157,[],CHEMBL941683,Antimycobacterial activity against Mycobacterium smegmatis ATCC 14468 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1140558,Bioorg Med Chem Lett,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,680750,=,1,1,=,,MIC,nM,,2080.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,uM,UO_0000065,,2.08
45843,,,2124468,[],CHEMBL953034,Inhibition of Mycobacterium leprae recombinant DNA gyrase expressed in Escherichia coli assessed as inhibition of pBR322 DNA supercoiling,B,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704407,=,1,1,=,,IC50,ug.mL-1,,2.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,IC50,ug ml-1,UO_0000274,,2.0
45844,,,2124481,[],CHEMBL953035,Effect on Mycobacterium leprae recombinant DNA gyrase expressed in Escherichia coli assessed as enhancement of supercoiled pBR322 DNA cleavage,B,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704407,=,1,0,=,,CC25,ug ml-1,,1.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,CC25,ug ml-1,UO_0000274,,1.0
45845,,Not Determined,2124494,[],CHEMBL953036,Antibacterial activity against Mycobacterium leprae at 5 ug/mL after 11 to 18 days,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,704407,,1,0,,,Activity,,,,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,Activity,,,,
45846,,Not Determined,2124502,[],CHEMBL938433,Antibacterial activity in Mycobacterium leprae infected mouse foot-pad model assessed as parasite killing after 9 months,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1145475,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,704407,,1,0,,,Activity,,,,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,,Activity,,,,
45847,,,2127017,[],CHEMBL936772,Antimicrobial activity against macrolide-susceptible Mycoplasma pneumoniae FH,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703070,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.063
45848,,,2127021,[],CHEMBL936773,Antimicrobial activity against macrolide-susceptible Mycoplasma pneumoniae Mac,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703070,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.063
45849,,,2127025,[],CHEMBL936774,Antimicrobial activity against macrolide-susceptible Mycoplasma pneumoniae M129,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703070,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.063
45850,,,2127029,[],CHEMBL936775,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae with 23S rRNA A2063G mutant isolate 1,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703070,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.031
45851,,,2127033,[],CHEMBL935914,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae with 23S rRNA A2063G mutant isolate 6,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703070,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.063
45852,,,2127037,[],CHEMBL935916,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae with 23S rRNA A2064G mutant isolate 4,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703070,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.031
45853,,,2127041,[],CHEMBL935915,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae with 23S rRNA A2064G mutant isolate 2,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143834,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703070,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.063
45854,,,2137550,[],CHEMBL937189,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144027,Bioorg Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,705315,=,1,1,=,,MIC,nM,,1040.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,1.04
45855,,,2137552,[],CHEMBL921202,Antimycobacterial activity against Mycobacterium smegmatis MC2 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144027,Bioorg Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,705315,=,1,1,=,,MIC,nM,,2080.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,uM,UO_0000065,,2.08
45856,,,2137554,[],CHEMBL921201,Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144027,Bioorg Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,705315,=,1,1,=,,MIC,nM,,8340.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,8.34
45857,,,2137556,[],CHEMBL921203,Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1144027,Bioorg Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,705315,>,1,1,>,,IC50,nM,,155300.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,uM,UO_0000065,,155.3
45858,,,2137557,[],CHEMBL921205,"Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35801 infected in CD1 mouse assessed as bacterial load in lungs at 50 mg/kg, ip after 10 days",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144027,Bioorg Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,705315,=,1,0,=,,Activity,,,6.02,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,6.02
45859,,,2137558,[],CHEMBL921206,"Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35801 infected in CD1 mouse assessed as bacterial load in spleen at 50 mg/kg, ip after 10 days",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1144027,Bioorg Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,705315,=,1,0,=,,Activity,,,6.92,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,6.92
45860,,,2144321,[],CHEMBL923686,"Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35801 infected in CD1 mouse assessed as bacterial load in lung at 50 mg/kg, ip after 10 days",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142419,Bioorg Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,696467,=,1,0,=,,Log10 cfu,,,6.02,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,6.02
45861,,,2144322,[],CHEMBL923687,"Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35801 infected in CD1 mouse assessed as bacterial load in spleen at 50 mg/kg, ip after 10 days",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142419,Bioorg Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,696467,=,1,0,=,,Log10 cfu,,,6.92,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Log10 cfu,,,,6.92
45862,,,2144339,[],CHEMBL933713,Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142419,Bioorg Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,696467,>,1,1,>,,IC50,nM,,155300.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,IC50,uM,UO_0000065,,155.3
45863,,,2144341,[],CHEMBL933712,Antimycobacterial activity against Mycobacterium smegmatis MC2 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142419,Bioorg Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,696467,=,1,1,=,,MIC,nM,,2080.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,uM,UO_0000065,,2.08
45864,,,2144343,[],CHEMBL933711,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142419,Bioorg Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,696467,=,1,1,=,,MIC,nM,,8340.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,8.34
45865,,,2144345,[],CHEMBL933710,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142419,Bioorg Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,696467,=,1,1,=,,MIC,nM,,1040.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,1.04
45866,,,2287219,[],CHEMBL1010779,Antibacterial activity against Mycobacterium tuberculosis H37Rv by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152865,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,731614,=,1,1,=,,MIC,nM,,1040.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,1.04
45867,,,2287269,[],CHEMBL1010780,Antibacterial activity against multidrug-resistant Mycobacterium tuberculosis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152865,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,731614,=,1,1,=,,MIC,nM,,8340.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,8.34
45868,,,2287319,[],CHEMBL1010781,Antibacterial activity against Mycobacterium smegmatis ATCC 14468 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152865,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,731614,=,1,1,=,,MIC,nM,,2080.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,uM,UO_0000065,,2.08
45869,,,2287369,[],CHEMBL1010782,Cytotoxicity against african green monkey Vero cells after 72 hrs by MTT assay,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152865,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,731614,>,1,1,>,,CC50,nM,,155300.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,CC50,uM,UO_0000065,,155.3
45870,,,2288456,[],CHEMBL1010783,"Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35801 infected in CD1 mouse assessed as bacterial load in lungs at 50 mg/kg, ip administered 10 days postinfection for 10 days measured after 35 days of infection",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152865,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,731614,=,1,0,=,,log10cfu,,,6.02,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log10cfu,,,,6.02
45871,,,2288457,[],CHEMBL1010785,"Antimycobacterial activity against Mycobacterium tuberculosis ATCC 35801 infected in CD1 mouse assessed as bacterial load in spleen at 50 mg/kg, ip administered 10 days postinfection for 10 days measured after 35 days of infection",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1152865,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,731614,=,1,0,=,,log10cfu,,,6.92,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log10cfu,,,,6.92
45872,,,2346418,[],CHEMBL954699,"Antimicrobial activity against Leptospira interrogans serovar Portlandvere infected golden Syrian hamster model of acute lethal leptospirosis assessed as survival at 25 mg/kg/day, ip once daily for 5 days administered 2 day after infection",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1150801,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,794016,=,1,0,=,,Survival,%,,100.0,CHEMBL613218,Leptospira interrogans serovar Portlandvere,Leptospira interrogans serovar Portlandvere,508528.0,,,Survival,%,UO_0000187,,100.0
45873,,,2346420,[],CHEMBL954698,"Antimicrobial activity against Leptospira interrogans serovar Portlandvere infected golden Syrian hamster model of acute lethal leptospirosis assessed as survival at 50 mg/kg/day, ip once daily for 5 days administered 2 day after infection",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1150801,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,794016,=,1,0,=,,Survival,%,,60.0,CHEMBL613218,Leptospira interrogans serovar Portlandvere,Leptospira interrogans serovar Portlandvere,508528.0,,,Survival,%,UO_0000187,,60.0
45874,,,2346422,[],CHEMBL954700,"Antimicrobial activity against Leptospira interrogans serovar Portlandvere infected golden Syrian hamster model of acute lethal leptospirosis assessed as survival at 5 mg/kg/day, ip once daily for 5 days administered 2 day after infection",F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1150801,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,794016,=,1,0,=,,Survival,%,,90.0,CHEMBL613218,Leptospira interrogans serovar Portlandvere,Leptospira interrogans serovar Portlandvere,508528.0,,,Survival,%,UO_0000187,,90.0
45875,,Toxic,2346424,[],CHEMBL954701,"Toxicity against Leptospira interrogans serovar Portlandvere infected golden Syrian hamster model of acute lethal leptospirosis assessed as induction of diarrhea at 50 mg/kg/day, ip once daily for 5 days administered 2 day after infection",T,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1150801,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,794016,,1,0,,,Activity,,,,CHEMBL612563,Mesocricetus auratus,Syrian golden hamster,10036.0,,,Activity,,,,
45876,,,2347412,[],CHEMBL957902,Antibacterial activity against Escherichia coli C600Rif by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793356,=,1,1,=,,MIC,ug.mL-1,,0.023,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.023
45877,,,2347419,[],CHEMBL957904,Antibacterial activity against Escherichia coli C600Rif in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793356,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
45878,,,2347426,[],CHEMBL957905,Antibacterial activity against Escherichia coli C600Rif in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793356,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
45879,,,2347433,[],CHEMBL957906,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793356,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.032
45880,,,2347440,[],CHEMBL957907,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793356,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
45881,,,2347447,[],CHEMBL957908,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793356,=,1,1,=,,MIC,ug.mL-1,,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.012
45882,,,2347454,[],CHEMBL957909,Antibacterial activity against Escherichia coli TOP10 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793356,=,1,1,=,,MIC,ug.mL-1,,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.003
45883,,,2347461,[],CHEMBL957910,Antibacterial activity against Escherichia coli TOP10 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793356,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
45884,,,2347468,[],CHEMBL957911,Antibacterial activity against Escherichia coli TOP10 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793356,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
45885,,,2347475,[],CHEMBL957912,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793356,=,1,1,=,,MIC,ug.mL-1,,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.003
45886,,,2347482,[],CHEMBL957913,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793356,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
45887,,,2347489,[],CHEMBL957914,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793356,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
45888,,,2347496,[],CHEMBL957915,Antibacterial activity against Escherichia coli TOP10 containing pAT851 plasmid by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793356,=,1,1,=,,MIC,ug.mL-1,,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.003
45889,,,2347503,[],CHEMBL957916,Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793356,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
45890,,,2347510,[],CHEMBL957917,Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793356,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
45891,,,2349389,[],CHEMBL956329,Antimicrobial activity against Acinetobacter baumannii 694 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794126,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
45892,,,2349402,[],CHEMBL956328,Antimicrobial activity against Acinetobacter baumannii 696 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794126,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.06
45893,,,2349415,[],CHEMBL956327,Antimicrobial activity against Acinetobacter baumannii 9043 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794126,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,4.0
45894,,,2349428,[],CHEMBL956325,Antimicrobial activity against Acinetobacter baumannii 695 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794126,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,4.0
45895,,,2349441,[],CHEMBL956324,Antimicrobial activity against Acinetobacter baumannii 501 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794126,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.12
45896,,,2349454,[],CHEMBL955555,Antimicrobial activity against Acinetobacter sp. 5227 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794126,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,,MIC,ug ml-1,UO_0000274,,1.0
45897,,,2349467,[],CHEMBL955554,Antimicrobial activity against Acinetobacter sp. 5248 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794126,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,,MIC,ug ml-1,UO_0000274,,4.0
45898,,,2349480,[],CHEMBL955553,Antimicrobial activity against Pseudomonas putida 12346 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794126,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL612501,Pseudomonas putida,Pseudomonas putida,303.0,,,MIC,ug ml-1,UO_0000274,,4.0
45899,,,2358305,[],CHEMBL954102,Inhibition of human ERG expressed in CHO cells by whole cell patch clamp technique,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1150324,Bioorg Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,1,http://www.openphacts.org/units/Nanomolar,767132,=,1,1,=,,IC50,nM,,128824.96,CHEMBL240,Homo sapiens,HERG,9606.0,,,pIC50,,UO_0000065,,3.89
45900,,,2467391,[],CHEMBL991709,Antibacterial activity against Staphylococcus aureus ATCC 13709 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142457,Bioorg Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,801576,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
45901,,Not Active,2467406,[],CHEMBL993351,"Protective effect against Staphylococcus aureus ATCC 13709-induced bone infection in CD rat at 10 mg/kg, iv administered as single dose 1 hr before bacterial challenge",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142457,Bioorg Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,801576,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
45902,,Not Active,2467407,[],CHEMBL992515,"Protective effect against Staphylococcus aureus ATCC 13709-induced bone infection in CD rat at 10 mg/kg, iv administered as single dose 2 days before bacterial challenge",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142457,Bioorg Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,801576,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
45903,,,2469855,[],CHEMBL983526,Antibacterial activity against Staphylococcus aureus ATCC 13709 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142491,J Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,801692,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
45904,,Not Active,2469857,[],CHEMBL1025785,"Protective effect against Staphylococcus aureus ATCC 13709-induced bone infection in CD rat at 20 mg/kg, iv administered as single dose 2 days before bacterial challenge",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142491,J Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,801692,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
45905,,,2469876,[],CHEMBL1025778,Binding affinity to bone assessed as drug level bound to cattle bone meal powder by fluorescence assay,B,,,BAO_0001103,BAO_0000221,tissue-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1142491,J Med Chem,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Percent,801692,=,1,0,=,,Activity,%,,0.01,CHEMBL4296530,Bos taurus,Bone,9913.0,,,Activity,%,UO_0000187,,0.01
45906,,,2499759,[],CHEMBL992264,Antimicrobial activity against multidrug-resistant Escherichia coli C316 pHPA containing mutated GyrA gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779191,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
45907,,,2499781,[],CHEMBL992265,Antimicrobial activity against Escherichia coli KAM32 expressing deltaacrB ydhE hsd gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779191,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
45908,,,2499803,[],CHEMBL992266,Antimicrobial activity against Escherichia coli KAM32 pHPA containing mutated GyrA gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779191,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
45909,,,2499825,[],CHEMBL992267,Antimicrobial activity against Escherichia coli KAM32 pSTV28 containing chloramphenicol-resistant vector by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779191,=,1,1,=,,MIC,ug.mL-1,,0.002,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.002
45910,,,2499847,[],CHEMBL992268,Antimicrobial activity against Escherichia coli KAM32 pSTVqepA containing qepA gene ligated to pSTV28 plasmid by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779191,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.016
45911,,,2499869,[],CHEMBL992269,Antimicrobial activity against Escherichia coli KAM32 pSTVdeltaqepA containing disrupted qepA gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779191,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
45912,,,2499891,[],CHEMBL992270,Ratio of MIC for Escherichia coli KAM32 pSTVqepA mutant to MIC for Escherichia coli KAM32 pSTV28 mutant,F,,,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,779191,=,1,0,=,,Ratio,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,8.0
45913,,,2514456,[],CHEMBL1014949,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by conventional agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138578,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,733387,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
45914,,,2514457,[],CHEMBL1014950,Antibacterial activity against Staphylococcus epidermidis ATCC 4940 after 18 hrs by conventional agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138578,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,733387,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.0625
45915,,,2514458,[],CHEMBL1014951,Antibacterial activity against Streptococcus pneumoniae ATCC 1240 after 18 hrs by conventional agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138578,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,733387,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
45916,,,2514459,[],CHEMBL1014952,Antibacterial activity against Bacillus subtilis ATCC 6051 after 18 hrs by conventional agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138578,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,733387,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.5
45917,,,2514460,[],CHEMBL1014953,Antibacterial activity against Enterococcus faecalis NCTC 6013 after 18 hrs by conventional agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138578,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,733387,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.5
45918,,,2514461,[],CHEMBL1014954,Antibacterial activity against Micrococcus luteus ATCC 1110 after 18 hrs by conventional agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138578,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,733387,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,1.0
45919,,,2514462,[],CHEMBL1014955,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by conventional agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138578,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,733387,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
45920,,,2514463,[],CHEMBL1014956,Antibacterial activity against Salmonella typhi ATCC 19430 after 18 hrs by conventional agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138578,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,733387,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL612532,Salmonella enterica subsp. enterica serovar Typhi str. CT18,Salmonella enterica subsp. enterica serovar Typhi str. CT18,220341.0,,,MIC,ug ml-1,UO_0000274,,0.0625
45921,,,2514464,[],CHEMBL1014957,Antibacterial activity against Shigella flexneri NCTC 8516 after 18 hrs by conventional agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138578,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,733387,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL614396,Shigella flexneri,Shigella flexneri,623.0,,,MIC,ug ml-1,UO_0000274,,0.0625
45922,,,2514465,[],CHEMBL1014958,Antibacterial activity against Klebsiella pneumoniae ATCC 10031 after 18 hrs by conventional agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138578,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,733387,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
45923,,,2514466,[],CHEMBL1014959,Antibacterial activity against Serratia marcescens PTCC 1111 after 18 hrs by conventional agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138578,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,733387,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.5
45924,,,2514467,[],CHEMBL1018499,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 hrs by conventional agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1138578,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,733387,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
45925,,,2514468,[],CHEMBL1018500,Cytotoxicity against mouse NIH/3T3 cells after 72 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1138578,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/Nanomolar,733387,=,1,1,=,,IC50,nM,,596000.0,CHEMBL612558,,ADMET,,,,IC50,uM,UO_0000065,,596.0
45926,,Active,2556442,[],CHEMBL993694,"Effect on growth of fluoroquinolone-resistant epidemic Clostridium difficile NAP1 in CF1 mouse assessed as increase in bacterial density in cecal content at 2.0 mg/day, sc for 5 days",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45927,,Active,2556443,[],CHEMBL993693,"Effect on growth of fluoroquinolone-resistant epidemic Clostridium difficile NAP1 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 5 days",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45928,,Active,2556444,[],CHEMBL993692,"Effect on growth of fluoroquinolone-resistant epidemic Clostridium difficile NAP1 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.375 mg/day, sc for 5 days",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45929,,,2556469,[],CHEMBL990922,Antimicrobial activity against nonepidemic Clostridium difficile ATCC 9689 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743671,<,1,1,<,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
45930,,,2556474,[],CHEMBL990923,Antimicrobial activity against nonepidemic Clostridium difficile J29 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743671,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,32.0
45931,,,2556479,[],CHEMBL990924,Antimicrobial activity against epidemic Clostridium difficile BI9 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743671,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
45932,,,2556484,[],CHEMBL990925,Antimicrobial activity against epidemic Clostridium difficile BI6-8-17 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743671,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,32.0
45933,,,2556489,[],CHEMBL990926,Antimicrobial activity against fluoroquinolone-resistant epidemic Clostridium difficile NAP1 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743671,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,256.0
45934,,,2556494,[],CHEMBL990927,Antimicrobial activity against fluoroquinolone-susceptible nonepidemic Clostridium difficile strain6 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743671,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
45935,,Active,2556497,[],CHEMBL994406,"Effect on growth of nonepidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45936,,Active,2556498,[],CHEMBL994407,"Effect on growth of nonepidemic Clostridium difficile J29 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45937,,Active,2556499,[],CHEMBL994408,"Effect on growth of epidemic Clostridium difficile BI9 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45938,,Active,2556500,[],CHEMBL994409,"Effect on growth of epidemic Clostridium difficile BI6-8-17 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45939,,Active,2556513,[],CHEMBL994410,"Effect on growth of nonepidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.375 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45940,,Active,2556514,[],CHEMBL994411,"Effect on growth of nonepidemic Clostridium difficile J29 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.375 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45941,,Active,2556515,[],CHEMBL994412,"Effect on growth of epidemic Clostridium difficile BI9 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.375 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45942,,Active,2556516,[],CHEMBL994413,"Effect on growth of epidemic Clostridium difficile BI6-8-17 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.375 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45943,,Active,2556517,[],CHEMBL994414,"Effect on growth of nonepidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45944,,Active,2556518,[],CHEMBL994415,"Effect on growth of nonepidemic Clostridium difficile J29 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45945,,Active,2556519,[],CHEMBL994416,"Effect on growth of epidemic Clostridium difficile BI9 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45946,,Active,2556520,[],CHEMBL994417,"Effect on growth of epidemic Clostridium difficile BI6-8-17 in CF1 mouse assessed as increase in bacterial density in cecal content at 0.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45947,,,2556543,[],CHEMBL993691,Drug level in Clostridium difficile infected CF1 mouse stool at 0.2 mg/day for 4 days,A,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,=,1,0,=,,Drug uptake,ug/g,,76.6,CHEMBL612558,,ADMET,,,,Drug uptake,ug/g,,,76.6
45948,,Active,2556561,[],CHEMBL994426,"Increase in toxin level in nonepidemic Clostridium difficile ATCC 9689 infected in CF1 mouse at 2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45949,,Active,2556562,[],CHEMBL994427,"Increase in toxin level in nonepidemic Clostridium difficile J29 infected CF1 mouse at 2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45950,,Active,2556565,[],CHEMBL994428,"Increase in toxin level in epidemic Clostridium difficile BI9 infected CF1 mouse at 2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45951,,Active,2556566,[],CHEMBL994429,"Increase in toxin level in epidemic Clostridium difficile BI6-8-17 infected CF1 mouse at 2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45952,,Active,2556567,[],CHEMBL994430,"Increase in toxin level in nonepidemic Clostridium difficile ATCC 9689 infected in CF1 mouse at 1.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45953,,Active,2556570,[],CHEMBL994431,"Increase in toxin level in nonepidemic Clostridium difficile J29 infected CF1 mouse at 1.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45954,,Active,2556572,[],CHEMBL994432,"Increase in toxin level in epidemic Clostridium difficile BI9 infected CF1 mouse at 1.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45955,,Active,2556574,[],CHEMBL990955,"Increase in toxin level in epidemic Clostridium difficile BI6-8-17 infected CF1 mouse at 1.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45956,,Active,2556576,[],CHEMBL993681,"Increase in toxin level in nonepidemic Clostridium difficile ATCC 9689 infected in CF1 mouse at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45957,,Active,2556578,[],CHEMBL993682,"Increase in toxin level in nonepidemic Clostridium difficile J29 infected CF1 mouse at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45958,,Active,2556580,[],CHEMBL993683,"Increase in toxin level in epidemic Clostridium difficile BI9 infected CF1 mouse at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45959,,Active,2556582,[],CHEMBL993684,"Increase in toxin level in epidemic Clostridium difficile BI6-8-17 infected CF1 mouse at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45960,,Not Active,2556585,[],CHEMBL993695,Effect on growth of fluoroquinolone-susceptible epidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content dosed sc for 5 days,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,743671,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
45961,,,2576494,[],CHEMBL988157,Antimicrobial activity against Clostridium difficile clinical isolates by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155149,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743070,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC50,ug ml-1,UO_0000274,,1.0
45962,,,2576495,[],CHEMBL988157,Antimicrobial activity against Clostridium difficile clinical isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1155149,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743070,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC90,ug ml-1,UO_0000274,,16.0
45963,,,2591604,[],CHEMBL1014577,Antitubercular activity against Mycobacterium tuberculosis H37Rv after 14 days by turbidimetric assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1139242,Bioorg Med Chem Lett,2008.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,749509,=,1,1,=,,MIC,ug.mL-1,,0.07,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.07
45964,,,2632650,[],CHEMBL963550,Antimycobacterial activity against Mycobacterium avium complex N016 infected C57BL/6J mouse assessed as spleen bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,783318,=,1,0,=,,log10cfu,,,6.81,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,6.81
45965,,,2632651,[],CHEMBL963549,Antimycobacterial activity against Mycobacterium avium complex N016 infected C57BL/6J mouse assessed as liver bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,783318,=,1,0,=,,log10cfu,,,6.6,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,6.6
45966,,,2632652,[],CHEMBL963548,Antimycobacterial activity against Mycobacterium avium complex N016 infected C57BL/6J mouse assessed as lung bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,783318,=,1,0,=,,log10cfu,,,5.48,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,5.48
45967,,,2632668,[],CHEMBL963544,Antimycobacterial activity against Mycobacterium intracellular JATA52-01 infected C57BL/6J mouse assessed as spleen bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,783318,=,1,0,=,,log10cfu,,,4.41,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,log10cfu,,,,4.41
45968,,,2632669,[],CHEMBL963543,Antimycobacterial activity against Mycobacterium intracellular JATA52-01 infected C57BL/6J mouse assessed as liver bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,783318,=,1,0,=,,log10cfu,,,5.15,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,log10cfu,,,,5.15
45969,,,2632670,[],CHEMBL963542,Antimycobacterial activity against Mycobacterium intracellular JATA52-01 infected C57BL/6J mouse assessed as lung bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,783318,=,1,0,=,,log10cfu,,,5.32,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,log10cfu,,,,5.32
45970,,,2632671,[],CHEMBL963538,Antimycobacterial activity against Mycobacterium avium JATA51-01 infected C57BL/6J mouse assessed as spleen bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,783318,=,1,0,=,,log10cfu,,,9.18,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,log10cfu,,,,9.18
45971,,,2632672,[],CHEMBL963537,Antimycobacterial activity against Mycobacterium avium JATA51-01 infected C57BL/6J mouse assessed as liver bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,783318,=,1,0,=,,log10cfu,,,9.91,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,log10cfu,,,,9.91
45972,,,2632673,[],CHEMBL963536,Antimycobacterial activity against Mycobacterium avium JATA51-01 infected C57BL/6J mouse assessed as lung bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,783318,=,1,0,=,,log10cfu,,,8.9,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,log10cfu,,,,8.9
45973,,,2632689,[],CHEMBL949908,Antimycobacterial activity against Mycobacterium avium complex N084 infected C57BL/6J mouse assessed as lung bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,783318,=,1,0,=,,log10cfu,,,8.14,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,8.14
45974,,,2632690,[],CHEMBL998999,Antimycobacterial activity against Mycobacterium avium complex N084 infected C57BL/6J mouse assessed as liver bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,783318,=,1,0,=,,log10cfu,,,8.0,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,8.0
45975,,,2632691,[],CHEMBL999000,Antimycobacterial activity against Mycobacterium avium complex N084 infected C57BL/6J mouse assessed as spleen bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,783318,=,1,0,=,,log10cfu,,,7.6,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,7.6
45976,,,2632703,[],CHEMBL962730,Antimycobacterial activity against Mycobacterium avium JATA51-01 after 14 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783318,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,ug ml-1,UO_0000274,,2.0
45977,,,2632704,[],CHEMBL962731,Antimycobacterial activity against Mycobacterium intracellular JATA52-01 after 14 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783318,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612640,Mycobacterium intracellulare,Mycobacterium intracellulare,1767.0,,,MIC,ug ml-1,UO_0000274,,1.0
45978,,,2632705,[],CHEMBL962732,Antimycobacterial activity against Mycobacterium avium complex N016 after 14 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783318,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,MIC,ug ml-1,UO_0000274,,0.5
45979,,,2632706,[],CHEMBL962733,Antimycobacterial activity against Mycobacterium avium complex N018 after 14 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783318,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,MIC,ug ml-1,UO_0000274,,1.0
45980,,,2632707,[],CHEMBL963534,Antimycobacterial activity against Mycobacterium avium complex N084 after 14 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783318,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,MIC,ug ml-1,UO_0000274,,1.0
45981,,,2632721,[],CHEMBL963535,Antimycobacterial activity against Mycobacterium avium complex after 14 days by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783318,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,MIC90,ug ml-1,UO_0000274,,4.0
45982,,,2632725,[],CHEMBL963554,Antimycobacterial activity against Mycobacterium avium complex N018 infected C57BL/6J mouse assessed as lung bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,783318,=,1,0,=,,log10cfu,,,5.96,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,5.96
45983,,,2632726,[],CHEMBL963555,Antimycobacterial activity against Mycobacterium avium complex N018 infected C57BL/6J mouse assessed as liver bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,783318,=,1,0,=,,log10cfu,,,7.21,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,7.21
45984,,,2632727,[],CHEMBL949904,Antimycobacterial activity against Mycobacterium avium complex N018 infected C57BL/6J mouse assessed as spleen bacterial count at 100 mg/kg/day dosed through gavage route administered for 28 days post bacterial challenge measured 2 days after last dose,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1137643,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,783318,=,1,0,=,,log10cfu,,,6.75,CHEMBL612953,Mycobacterium avium complex sp.,Mycobacterium avium complex sp.,37162.0,,,log10cfu,,,,6.75
45985,,,2645542,[],CHEMBL1023674,Inhibition of human ERG in MCF7 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1158373,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,1,http://www.openphacts.org/units/Nanomolar,814291,=,1,1,=,,IC50,nM,,128824.96,CHEMBL240,Homo sapiens,HERG,9606.0,,,pIC50,,UO_0000065,,3.89
45986,,,2645579,[],CHEMBL1023675,"Lipophilicity, log D at pH 7.0",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1158373,Eur J Med Chem,2009.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,814291,=,1,1,=,,LogD,,,-2.96,CHEMBL2362975,,No relevant target,,,,logD,,,,-2.96
45987,,,2659337,[],CHEMBL1026180,Antimicrobial activity against Bacillus anthracis Ames after 18 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151423,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817873,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,MIC,mg/L,UO_0000274,,0.125
45988,,,2659338,[],CHEMBL1026181,"Apparent volume of distribution with respect to the bioavailability in mouse at 10 to 100 mg/kg, ip",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151423,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,817873,=,1,0,=,,Vc/F,L/hr,,0.2,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Vc/F,L/hr,,,0.2
45989,,,2659339,[],CHEMBL1026179,"Apparent peripheral volume of distribution in mouse at 10 to 100 mg/kg, ip",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151423,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,817873,=,1,0,=,,Vp/F,L/hr,,1.6,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Vp/F,L/hr,,,1.6
45990,,,2659340,[],CHEMBL1026177,"Apparent distribution clearance in mouse at 10 to 100 mg/kg, ip",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151423,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,817873,=,1,1,=,,CL/F,mL.min-1.kg-1,,128.33,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CLd/F,L/hr/kg,,,7.7
45991,,,2659341,[],CHEMBL1026182,"Apparent total clearance in mouse at 10 to 100 mg/kg, ip",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151423,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,817873,=,1,1,=,,CL/F,mL.min-1.kg-1,,45.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CLt/F,L/hr/kg,,,2.7
45992,,,2659342,[],CHEMBL1026178,"Tlag in mouse at 10 to 100 mg/kg, ip",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151423,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Hour,817873,=,1,0,=,,Tlag,hr,,0.23,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Tlag,hr,UO_0000032,,0.23
45993,,,2659343,[],CHEMBL1026176,"Half life in mouse at 10 to 100 mg/kg, ip",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151423,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Hour,817873,=,1,1,=,,T1/2,hr,,0.6,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,t1/2,hr,UO_0000032,,0.6
45994,,,2659344,[],CHEMBL1026174,Apparent total clearance in human,A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151423,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,817873,=,1,1,=,,CL/F,mL.min-1.kg-1,,1.667,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CLt/F,L/hr/kg,,,0.1
45995,,,2659345,[],CHEMBL1026175,Half life in human,A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151423,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://qudt.org/vocab/unit#Hour,817873,=,1,1,=,,T1/2,hr,,9.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,9.0
45996,,,2659346,[],CHEMBL1026183,Ratio of AUC (0 to 24 hrs) for Staphylococcus infected patient to MIC for Staphylococcus,F,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151423,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,817873,=,1,0,=,,Ratio,,,85.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,85.0
45997,,,2659347,[],CHEMBL1026184,Ratio of AUC (0 to 24 hrs) for Enterococcus infected patient to MIC for Enterococcus,F,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151423,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,817873,=,1,0,=,,Ratio,,,85.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,85.0
45998,,,2659348,[],CHEMBL1026185,Ratio of AUC (0 to 24 hrs) for Staphylococcus aureus infected ICR/Swiss mouse model to MIC for Staphylococcus aureus,F,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151423,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,817873,=,1,0,=,,Ratio,,,83.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,83.0
45999,,,2662323,[],CHEMBL1023541,Antimicrobial activity against Escherichia coli DH10B expressing pCRQB10 in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818895,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
